WO1996006837A1 - Isoxazoles - Google Patents
Isoxazoles Download PDFInfo
- Publication number
- WO1996006837A1 WO1996006837A1 PCT/JP1995/001714 JP9501714W WO9606837A1 WO 1996006837 A1 WO1996006837 A1 WO 1996006837A1 JP 9501714 W JP9501714 W JP 9501714W WO 9606837 A1 WO9606837 A1 WO 9606837A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- acceptable salt
- pharmaceutically acceptable
- aminoethoxy
- benzoisoxazole
- Prior art date
Links
- 150000002545 isoxazoles Chemical class 0.000 title claims abstract description 37
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 46
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 37
- 125000004414 alkyl thio group Chemical group 0.000 claims abstract description 26
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 24
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 23
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract description 20
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 20
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 20
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 19
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims abstract description 18
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 13
- 150000002367 halogens Chemical group 0.000 claims abstract description 9
- 229910052717 sulfur Chemical group 0.000 claims abstract description 8
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 7
- 125000004423 acyloxy group Chemical group 0.000 claims abstract description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000001301 oxygen Substances 0.000 claims abstract description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 6
- 125000005236 alkanoylamino group Chemical group 0.000 claims abstract description 5
- -1 formylamino group Chemical group 0.000 claims description 833
- 150000001875 compounds Chemical class 0.000 claims description 489
- 150000003839 salts Chemical class 0.000 claims description 197
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 77
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 60
- KTZQTRPPVKQPFO-UHFFFAOYSA-N 1,2-benzoxazole Chemical compound C1=CC=C2C=NOC2=C1 KTZQTRPPVKQPFO-UHFFFAOYSA-N 0.000 claims description 50
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical group C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims description 44
- 125000003277 amino group Chemical group 0.000 claims description 42
- 239000003795 chemical substances by application Substances 0.000 claims description 33
- 229910052757 nitrogen Inorganic materials 0.000 claims description 29
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 28
- 125000003282 alkyl amino group Chemical group 0.000 claims description 26
- 125000005843 halogen group Chemical group 0.000 claims description 26
- 239000004480 active ingredient Substances 0.000 claims description 24
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 24
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 23
- 229940123685 Monoamine oxidase inhibitor Drugs 0.000 claims description 22
- 239000002899 monoamine oxidase inhibitor Substances 0.000 claims description 22
- 229910052801 chlorine Inorganic materials 0.000 claims description 19
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 claims description 19
- 125000004076 pyridyl group Chemical group 0.000 claims description 19
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- 229910052731 fluorine Inorganic materials 0.000 claims description 18
- 125000001153 fluoro group Chemical group F* 0.000 claims description 17
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 17
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 16
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 claims description 16
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 16
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims description 16
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 15
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 15
- 125000006239 protecting group Chemical group 0.000 claims description 14
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 claims description 13
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 13
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 13
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims description 12
- 125000001624 naphthyl group Chemical group 0.000 claims description 12
- 125000004434 sulfur atom Chemical group 0.000 claims description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 11
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 11
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims description 11
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 11
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims description 11
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 claims description 10
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims description 10
- 125000005842 heteroatom Chemical group 0.000 claims description 10
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims description 8
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims description 7
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 claims description 7
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 claims description 6
- 125000002541 furyl group Chemical group 0.000 claims description 6
- 125000002883 imidazolyl group Chemical group 0.000 claims description 6
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 6
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 6
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims description 5
- 125000006012 2-chloroethoxy group Chemical group 0.000 claims description 5
- 125000004791 2-fluoroethoxy group Chemical group FCCO* 0.000 claims description 5
- 125000004651 chloromethoxy group Chemical group ClCO* 0.000 claims description 5
- 125000001786 isothiazolyl group Chemical group 0.000 claims description 5
- 125000002971 oxazolyl group Chemical group 0.000 claims description 5
- 125000000335 thiazolyl group Chemical group 0.000 claims description 5
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 5
- 125000004790 1-fluoroethoxy group Chemical group FC(C)O* 0.000 claims description 4
- WYKLEIJKFBUWAC-UHFFFAOYSA-N 2-(1,2-benzoxazol-3-ylsulfanyl)ethanamine Chemical compound C1=CC=C2C(SCCN)=NOC2=C1 WYKLEIJKFBUWAC-UHFFFAOYSA-N 0.000 claims description 4
- JRQCHSDHISFAQB-UHFFFAOYSA-N 2-[(4-fluoro-1,2-benzoxazol-3-yl)oxy]ethanamine Chemical compound C1=CC(F)=C2C(OCCN)=NOC2=C1 JRQCHSDHISFAQB-UHFFFAOYSA-N 0.000 claims description 4
- YKNIVXNITSJDFA-UHFFFAOYSA-N 2-[(4-fluoro-1,2-benzoxazol-3-yl)sulfanyl]ethanamine Chemical compound C1=CC(F)=C2C(SCCN)=NOC2=C1 YKNIVXNITSJDFA-UHFFFAOYSA-N 0.000 claims description 4
- FPYHDQYHBLQBFJ-UHFFFAOYSA-N 3-(2-aminoethoxy)-1,2-benzoxazole-4-carbonitrile Chemical compound C1=CC(C#N)=C2C(OCCN)=NOC2=C1 FPYHDQYHBLQBFJ-UHFFFAOYSA-N 0.000 claims description 4
- OGQAMVFSUMMBQF-UHFFFAOYSA-N 3-(2-aminoethoxy)-1,2-benzoxazole-4-carboxylic acid Chemical compound C1=CC(C(O)=O)=C2C(OCCN)=NOC2=C1 OGQAMVFSUMMBQF-UHFFFAOYSA-N 0.000 claims description 4
- XFGRIHCIBHDXMP-UHFFFAOYSA-N 3-(2-aminoethoxy)-n,n-dimethyl-1,2-benzoxazol-4-amine Chemical compound CN(C)C1=CC=CC2=C1C(OCCN)=NO2 XFGRIHCIBHDXMP-UHFFFAOYSA-N 0.000 claims description 4
- AWNJLVTZSUBWJX-UHFFFAOYSA-N 3-(2-aminoethoxy)-n-methyl-1,2-benzoxazol-4-amine Chemical compound CNC1=CC=CC2=C1C(OCCN)=NO2 AWNJLVTZSUBWJX-UHFFFAOYSA-N 0.000 claims description 4
- 102000004316 Oxidoreductases Human genes 0.000 claims description 4
- 108090000854 Oxidoreductases Proteins 0.000 claims description 4
- ZJKIQZRCKCHTIF-UHFFFAOYSA-N [3-(2-aminoethoxy)-1,2-benzoxazol-4-yl] acetate Chemical compound CC(=O)OC1=CC=CC2=C1C(OCCN)=NO2 ZJKIQZRCKCHTIF-UHFFFAOYSA-N 0.000 claims description 4
- 125000004783 dichloromethoxy group Chemical group ClC(O*)Cl 0.000 claims description 4
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 claims description 4
- FESXVCBVKQCJLL-UHFFFAOYSA-N methyl 3-(2-aminoethoxy)-1,2-benzoxazole-4-carboxylate Chemical compound COC(=O)C1=CC=CC2=C1C(OCCN)=NO2 FESXVCBVKQCJLL-UHFFFAOYSA-N 0.000 claims description 4
- 125000002757 morpholinyl group Chemical group 0.000 claims description 4
- 125000004784 trichloromethoxy group Chemical group ClC(O*)(Cl)Cl 0.000 claims description 4
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 claims description 3
- SUBDMHAZFILTMA-UHFFFAOYSA-N 2-(1,2-benzoxazol-3-yloxy)ethanamine Chemical group C1=CC=C2C(OCCN)=NOC2=C1 SUBDMHAZFILTMA-UHFFFAOYSA-N 0.000 claims description 3
- KQNORQUATFHFEJ-UHFFFAOYSA-N 2-[(4-methoxy-1,2-benzoxazol-3-yl)sulfanyl]ethanamine Chemical compound COC1=CC=CC2=C1C(SCCN)=NO2 KQNORQUATFHFEJ-UHFFFAOYSA-N 0.000 claims description 3
- HWFUFAHUPQZFAF-UHFFFAOYSA-N 2-[(5-chloro-4-methyl-1,2-benzoxazol-3-yl)sulfanyl]ethanamine Chemical compound CC1=C(Cl)C=CC2=C1C(SCCN)=NO2 HWFUFAHUPQZFAF-UHFFFAOYSA-N 0.000 claims description 3
- DERIBKYUISDLKE-UHFFFAOYSA-N 2-[(5-fluoro-4-methyl-1,2-benzoxazol-3-yl)oxy]ethanamine Chemical compound CC1=C(F)C=CC2=C1C(OCCN)=NO2 DERIBKYUISDLKE-UHFFFAOYSA-N 0.000 claims description 3
- MRHXWHMWRWBXPT-UHFFFAOYSA-N 2-[(5-fluoro-4-methyl-1,2-benzoxazol-3-yl)sulfanyl]ethanamine Chemical compound CC1=C(F)C=CC2=C1C(SCCN)=NO2 MRHXWHMWRWBXPT-UHFFFAOYSA-N 0.000 claims description 3
- TXEUWCDEXFTFOX-UHFFFAOYSA-N 2-[[4-(difluoromethoxy)-1,2-benzoxazol-3-yl]oxy]ethanamine Chemical compound C1=CC(OC(F)F)=C2C(OCCN)=NOC2=C1 TXEUWCDEXFTFOX-UHFFFAOYSA-N 0.000 claims description 3
- WHWZEMYCHZIGRI-UHFFFAOYSA-N 3-(2-aminoethoxy)-1,2-benzoxazol-4-amine Chemical compound C1=CC(N)=C2C(OCCN)=NOC2=C1 WHWZEMYCHZIGRI-UHFFFAOYSA-N 0.000 claims description 3
- GXMJARKYNVLOHD-UHFFFAOYSA-N 3-(2-aminoethoxy)-1,2-benzoxazol-4-ol Chemical compound C1=CC(O)=C2C(OCCN)=NOC2=C1 GXMJARKYNVLOHD-UHFFFAOYSA-N 0.000 claims description 3
- BVMGPZOJCJUVQM-UHFFFAOYSA-N 3-(2-aminoethoxy)-5-fluoro-1,2-benzoxazole-4-carbonitrile Chemical compound C1=C(F)C(C#N)=C2C(OCCN)=NOC2=C1 BVMGPZOJCJUVQM-UHFFFAOYSA-N 0.000 claims description 3
- LHHLIDIREUAEMH-UHFFFAOYSA-N 3-(2-aminoethylsulfanyl)-5-fluoro-1,2-benzoxazole-4-carbonitrile Chemical compound C1=C(F)C(C#N)=C2C(SCCN)=NOC2=C1 LHHLIDIREUAEMH-UHFFFAOYSA-N 0.000 claims description 3
- WKFBSLGHYSYFTB-UHFFFAOYSA-N NCCOC1=NOC2=C1C(=CC=C2)C(=O)OCF Chemical compound NCCOC1=NOC2=C1C(=CC=C2)C(=O)OCF WKFBSLGHYSYFTB-UHFFFAOYSA-N 0.000 claims description 3
- 125000002252 acyl group Chemical group 0.000 claims description 3
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims description 3
- 230000002140 halogenating effect Effects 0.000 claims description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 3
- QEDKIMTWUSUOQJ-UHFFFAOYSA-N 2-(1,2-benzoxazol-3-yloxy)ethanamine;hydrochloride Chemical compound Cl.C1=CC=C2C(OCCN)=NOC2=C1 QEDKIMTWUSUOQJ-UHFFFAOYSA-N 0.000 claims description 2
- WIHLTDCKQDTWDS-UHFFFAOYSA-N 2-([1,2]oxazolo[5,4-b]pyridin-3-yloxy)ethanamine Chemical compound C1=CC=C2C(OCCN)=NOC2=N1 WIHLTDCKQDTWDS-UHFFFAOYSA-N 0.000 claims description 2
- WKMLARMIRUVDDF-UHFFFAOYSA-N 2-pyridin-3-yloxyethanamine Chemical compound NCCOC1=CC=CN=C1 WKMLARMIRUVDDF-UHFFFAOYSA-N 0.000 claims description 2
- QOZYHGXYZDSBCT-UHFFFAOYSA-N 3-(2-aminoethylsulfanyl)-1,2-benzoxazol-4-amine Chemical compound C1=CC(N)=C2C(SCCN)=NOC2=C1 QOZYHGXYZDSBCT-UHFFFAOYSA-N 0.000 claims description 2
- 241000180579 Arca Species 0.000 claims description 2
- XUTIDUCSRSNKKP-UHFFFAOYSA-N [1,2]oxazolo[4,5-b]pyridine Chemical compound C1=CN=C2C=NOC2=C1 XUTIDUCSRSNKKP-UHFFFAOYSA-N 0.000 claims description 2
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 125000002950 monocyclic group Chemical group 0.000 claims description 2
- VTNNRSCZZAAIRH-UHFFFAOYSA-N 2-[(4,5-dimethyl-1,2-benzoxazol-3-yl)oxy]ethanamine Chemical compound CC1=CC=C2ON=C(OCCN)C2=C1C VTNNRSCZZAAIRH-UHFFFAOYSA-N 0.000 claims 2
- DYBXCMNSCOWBGS-UHFFFAOYSA-N 2-[(4-methoxy-1,2-benzoxazol-3-yl)oxy]ethanamine Chemical compound COC1=CC=CC2=C1C(OCCN)=NO2 DYBXCMNSCOWBGS-UHFFFAOYSA-N 0.000 claims 2
- XXBFVDLLXFDEAB-UHFFFAOYSA-N 2-[(4-methoxy-5-methyl-1,2-benzoxazol-3-yl)oxy]ethanamine Chemical compound COC1=C(C)C=CC2=C1C(OCCN)=NO2 XXBFVDLLXFDEAB-UHFFFAOYSA-N 0.000 claims 2
- YGOUABKMKHWASB-UHFFFAOYSA-N 2-[(4-methyl-1,2-benzoxazol-3-yl)oxy]ethanamine Chemical compound CC1=CC=CC2=C1C(OCCN)=NO2 YGOUABKMKHWASB-UHFFFAOYSA-N 0.000 claims 2
- XWZRNQIAZHIMGS-UHFFFAOYSA-N 2-[(4-methyl-1,2-benzoxazol-3-yl)sulfanyl]ethanamine Chemical compound CC1=CC=CC2=C1C(SCCN)=NO2 XWZRNQIAZHIMGS-UHFFFAOYSA-N 0.000 claims 2
- BRVWVMXWZGQHAE-UHFFFAOYSA-N 2-[(5,6-dichloro-4-methyl-1,2-benzoxazol-3-yl)oxy]ethanamine Chemical compound CC1=C(Cl)C(Cl)=CC2=C1C(OCCN)=NO2 BRVWVMXWZGQHAE-UHFFFAOYSA-N 0.000 claims 2
- VASKIQYHXPUPPM-UHFFFAOYSA-N 2-[(5-bromo-4-methyl-1,2-benzoxazol-3-yl)oxy]ethanamine Chemical compound CC1=C(Br)C=CC2=C1C(OCCN)=NO2 VASKIQYHXPUPPM-UHFFFAOYSA-N 0.000 claims 2
- KZAOQTSNULKRJW-UHFFFAOYSA-N 2-[(5-chloro-4-methyl-1,2-benzoxazol-3-yl)oxy]ethanamine Chemical compound CC1=C(Cl)C=CC2=C1C(OCCN)=NO2 KZAOQTSNULKRJW-UHFFFAOYSA-N 0.000 claims 2
- RKXFBGJKYRLGKS-UHFFFAOYSA-N 2-[(5-fluoro-4-methylsulfanyl-1,2-benzoxazol-3-yl)oxy]ethanamine Chemical compound CSC1=C(F)C=CC2=C1C(OCCN)=NO2 RKXFBGJKYRLGKS-UHFFFAOYSA-N 0.000 claims 2
- BELMEMTVYOSDMU-UHFFFAOYSA-N 2-[(5-methyl-4-methylsulfanyl-1,2-benzoxazol-3-yl)oxy]ethanamine Chemical compound CSC1=C(C)C=CC2=C1C(OCCN)=NO2 BELMEMTVYOSDMU-UHFFFAOYSA-N 0.000 claims 2
- XBBYRUWPNCKLMV-UHFFFAOYSA-N 3-(2-aminoethoxy)-5-chloro-1,2-benzoxazole-4-carbonitrile Chemical compound C1=C(Cl)C(C#N)=C2C(OCCN)=NOC2=C1 XBBYRUWPNCKLMV-UHFFFAOYSA-N 0.000 claims 2
- QSWDMIMSEKPSMN-UHFFFAOYSA-N 3-(2-aminoethoxy)-5-methyl-1,2-benzoxazole-4-carbonitrile Chemical compound CC1=CC=C2ON=C(OCCN)C2=C1C#N QSWDMIMSEKPSMN-UHFFFAOYSA-N 0.000 claims 2
- KUQWITIWZYJFCX-UHFFFAOYSA-N 3-(2-aminoethylsulfanyl)-5-chloro-1,2-benzoxazole-4-carbonitrile Chemical compound C1=C(Cl)C(C#N)=C2C(SCCN)=NOC2=C1 KUQWITIWZYJFCX-UHFFFAOYSA-N 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- FKQKAGNYKFWVIQ-UHFFFAOYSA-N methyl 3-(2-aminoethoxy)-5-methyl-1,2-benzoxazole-4-carboxylate Chemical compound COC(=O)C1=C(C)C=CC2=C1C(OCCN)=NO2 FKQKAGNYKFWVIQ-UHFFFAOYSA-N 0.000 claims 2
- 238000005580 one pot reaction Methods 0.000 claims 2
- QUBXULZTCLXFRV-UHFFFAOYSA-N 1,2-oxazole-3-carbonitrile Chemical class N#CC=1C=CON=1 QUBXULZTCLXFRV-UHFFFAOYSA-N 0.000 claims 1
- PEBJXXVNTBMJJU-UHFFFAOYSA-N 2-[(4-bromo-1,2-benzoxazol-3-yl)oxy]ethanamine Chemical compound C1=CC(Br)=C2C(OCCN)=NOC2=C1 PEBJXXVNTBMJJU-UHFFFAOYSA-N 0.000 claims 1
- RCVGIDSSSHKUIC-UHFFFAOYSA-N 2-[[4-(trifluoromethyl)-1,2-benzoxazol-3-yl]oxy]ethanamine Chemical compound C1=CC(C(F)(F)F)=C2C(OCCN)=NOC2=C1 RCVGIDSSSHKUIC-UHFFFAOYSA-N 0.000 claims 1
- HJAHBIVCIBTCHA-UHFFFAOYSA-N C1=CC(=C2C(=C1)ON=C2OCCN)CF Chemical compound C1=CC(=C2C(=C1)ON=C2OCCN)CF HJAHBIVCIBTCHA-UHFFFAOYSA-N 0.000 claims 1
- 229940087098 Oxidase inhibitor Drugs 0.000 claims 1
- 235000010290 biphenyl Nutrition 0.000 claims 1
- 239000004305 biphenyl Substances 0.000 claims 1
- 125000006267 biphenyl group Chemical group 0.000 claims 1
- 239000004020 conductor Substances 0.000 claims 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 375
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract description 115
- 230000002401 inhibitory effect Effects 0.000 abstract description 25
- 102000010909 Monoamine Oxidase Human genes 0.000 abstract description 22
- 108010062431 Monoamine oxidase Proteins 0.000 abstract description 22
- 208000018737 Parkinson disease Diseases 0.000 abstract description 13
- 230000003449 preventive effect Effects 0.000 abstract description 3
- 239000001257 hydrogen Substances 0.000 abstract description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical group C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 195
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 170
- 239000002904 solvent Substances 0.000 description 168
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 165
- 238000002329 infrared spectrum Methods 0.000 description 149
- 238000002844 melting Methods 0.000 description 138
- 230000008018 melting Effects 0.000 description 138
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 130
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 96
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 94
- 238000001228 spectrum Methods 0.000 description 93
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 92
- 238000000354 decomposition reaction Methods 0.000 description 80
- 239000000243 solution Substances 0.000 description 77
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 72
- ZMXDDKWLCZADIW-UHFFFAOYSA-N Vilsmeier-Haack reagent Natural products CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 72
- 239000007858 starting material Substances 0.000 description 65
- 239000000203 mixture Substances 0.000 description 64
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 60
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 57
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 48
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 48
- 238000007796 conventional method Methods 0.000 description 48
- 238000000034 method Methods 0.000 description 47
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 46
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 45
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 45
- 230000002829 reductive effect Effects 0.000 description 44
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 43
- 239000012044 organic layer Substances 0.000 description 42
- 239000003153 chemical reaction reagent Substances 0.000 description 38
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 37
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 36
- 239000002585 base Substances 0.000 description 34
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 34
- 150000002170 ethers Chemical class 0.000 description 30
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 29
- 239000000843 powder Substances 0.000 description 29
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 28
- 150000001408 amides Chemical class 0.000 description 28
- 239000011541 reaction mixture Substances 0.000 description 28
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 27
- 239000012442 inert solvent Substances 0.000 description 26
- 150000008282 halocarbons Chemical class 0.000 description 25
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 24
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 24
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 24
- 238000001953 recrystallisation Methods 0.000 description 24
- 239000002253 acid Substances 0.000 description 23
- 238000004587 chromatography analysis Methods 0.000 description 23
- 238000001226 reprecipitation Methods 0.000 description 23
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 22
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 22
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 22
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 22
- 230000035484 reaction time Effects 0.000 description 22
- 238000003756 stirring Methods 0.000 description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- 229910052783 alkali metal Inorganic materials 0.000 description 21
- 238000010898 silica gel chromatography Methods 0.000 description 21
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 20
- 125000001246 bromo group Chemical group Br* 0.000 description 20
- 238000001816 cooling Methods 0.000 description 20
- 239000005457 ice water Substances 0.000 description 20
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 19
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 18
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 17
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 17
- 150000003462 sulfoxides Chemical class 0.000 description 17
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 16
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 16
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 16
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 16
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 16
- 125000006630 butoxycarbonylamino group Chemical group 0.000 description 16
- 229940117389 dichlorobenzene Drugs 0.000 description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 15
- 239000012046 mixed solvent Substances 0.000 description 15
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 14
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 14
- 239000003208 petroleum Substances 0.000 description 14
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 14
- 239000008096 xylene Substances 0.000 description 14
- 229910021529 ammonia Inorganic materials 0.000 description 13
- 239000013078 crystal Substances 0.000 description 13
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 13
- 150000002148 esters Chemical class 0.000 description 13
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 13
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 12
- 150000001412 amines Chemical class 0.000 description 12
- 229910052744 lithium Inorganic materials 0.000 description 12
- 229910000027 potassium carbonate Inorganic materials 0.000 description 12
- 235000011181 potassium carbonates Nutrition 0.000 description 12
- 229910000029 sodium carbonate Inorganic materials 0.000 description 12
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 12
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 11
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 11
- 150000001298 alcohols Chemical class 0.000 description 11
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 11
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 11
- 229910052808 lithium carbonate Inorganic materials 0.000 description 11
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 11
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 11
- 235000017557 sodium bicarbonate Nutrition 0.000 description 11
- 239000012312 sodium hydride Substances 0.000 description 11
- 229910000104 sodium hydride Inorganic materials 0.000 description 11
- 125000001424 substituent group Chemical group 0.000 description 11
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 10
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 10
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 10
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 10
- 150000008041 alkali metal carbonates Chemical class 0.000 description 10
- 150000001340 alkali metals Chemical class 0.000 description 10
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 10
- 239000010410 layer Substances 0.000 description 10
- 229910000103 lithium hydride Inorganic materials 0.000 description 10
- HQRPHMAXFVUBJX-UHFFFAOYSA-M lithium;hydrogen carbonate Chemical compound [Li+].OC([O-])=O HQRPHMAXFVUBJX-UHFFFAOYSA-M 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 9
- 150000008065 acid anhydrides Chemical class 0.000 description 9
- 239000003513 alkali Substances 0.000 description 9
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 9
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 8
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
- 239000000460 chlorine Substances 0.000 description 8
- 239000012299 nitrogen atmosphere Substances 0.000 description 8
- 239000003960 organic solvent Substances 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- GPTXCAZYUMDUMN-UHFFFAOYSA-N tert-butyl n-(2-hydroxyethyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCO GPTXCAZYUMDUMN-UHFFFAOYSA-N 0.000 description 8
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 7
- 150000008046 alkali metal hydrides Chemical class 0.000 description 7
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 7
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 7
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 7
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 description 7
- 229910000032 lithium hydrogen carbonate Inorganic materials 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 7
- QVCUKHQDEZNNOC-UHFFFAOYSA-N 1,2-diazabicyclo[2.2.2]octane Chemical compound C1CC2CCN1NC2 QVCUKHQDEZNNOC-UHFFFAOYSA-N 0.000 description 6
- YUKUDJRCHPSDGC-UHFFFAOYSA-N 1,2-oxazole;hydrochloride Chemical compound Cl.C=1C=NOC=1 YUKUDJRCHPSDGC-UHFFFAOYSA-N 0.000 description 6
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 6
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 6
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 6
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 6
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 6
- BLHLJVCOVBYQQS-UHFFFAOYSA-N ethyllithium Chemical compound [Li]CC BLHLJVCOVBYQQS-UHFFFAOYSA-N 0.000 description 6
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 6
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 6
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 6
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 5
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 5
- 208000012902 Nervous system disease Diseases 0.000 description 5
- 208000025966 Neurological disease Diseases 0.000 description 5
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 150000008064 anhydrides Chemical class 0.000 description 5
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 5
- 239000001569 carbon dioxide Substances 0.000 description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 5
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 125000006626 methoxycarbonylamino group Chemical group 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 239000007800 oxidant agent Substances 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- WOSQDCFVYQABKO-UHFFFAOYSA-N 1,2-benzoxazol-2-ium;chloride Chemical compound Cl.C1=CC=C2C=NOC2=C1 WOSQDCFVYQABKO-UHFFFAOYSA-N 0.000 description 4
- WORJRXHJTUTINR-UHFFFAOYSA-N 1,4-dioxane;hydron;chloride Chemical compound Cl.C1COCCO1 WORJRXHJTUTINR-UHFFFAOYSA-N 0.000 description 4
- GAUKCDPSYQUYQL-UHFFFAOYSA-N 3-methyl-1,2-benzoxazole Chemical compound C1=CC=C2C(C)=NOC2=C1 GAUKCDPSYQUYQL-UHFFFAOYSA-N 0.000 description 4
- 208000024827 Alzheimer disease Diseases 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 4
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 125000001931 aliphatic group Chemical group 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 125000003710 aryl alkyl group Chemical group 0.000 description 4
- HKVFISRIUUGTIB-UHFFFAOYSA-O azanium;cerium;nitrate Chemical compound [NH4+].[Ce].[O-][N+]([O-])=O HKVFISRIUUGTIB-UHFFFAOYSA-O 0.000 description 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 238000010531 catalytic reduction reaction Methods 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 4
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 4
- KIWBPDUYBMNFTB-UHFFFAOYSA-M ethyl sulfate Chemical compound CCOS([O-])(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-M 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 4
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 229920005610 lignin Polymers 0.000 description 4
- JILPJDVXYVTZDQ-UHFFFAOYSA-N lithium methoxide Chemical compound [Li+].[O-]C JILPJDVXYVTZDQ-UHFFFAOYSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 4
- 229910052763 palladium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229960003975 potassium Drugs 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 4
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 4
- QLDQYRDCPNBPII-UHFFFAOYSA-N 1,2-benzoxazol-3-one Chemical compound C1=CC=C2C(O)=NOC2=C1 QLDQYRDCPNBPII-UHFFFAOYSA-N 0.000 description 3
- YQTMYTBXEPKNOP-UHFFFAOYSA-N 1,2-benzoxazol-7-amine Chemical compound NC1=CC=CC2=C1ON=C2 YQTMYTBXEPKNOP-UHFFFAOYSA-N 0.000 description 3
- 125000006176 2-ethylbutyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 3
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 3
- 125000005916 2-methylpentyl group Chemical group 0.000 description 3
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 3
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 3
- JJDNTIJMCMIVES-UHFFFAOYSA-N 3-chloro-7-methyl-1,2-benzoxazole Chemical compound CC1=CC=CC2=C1ON=C2Cl JJDNTIJMCMIVES-UHFFFAOYSA-N 0.000 description 3
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 3
- XKGWNLWYKSSVKG-UHFFFAOYSA-N 7-methyl-1,2-benzoxazole Chemical compound CC1=CC=CC2=C1ON=C2 XKGWNLWYKSSVKG-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241001024304 Mino Species 0.000 description 3
- 229920000881 Modified starch Polymers 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 3
- 150000001335 aliphatic alkanes Chemical class 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 125000005129 aryl carbonyl group Chemical group 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- RCJVRSBWZCNNQT-UHFFFAOYSA-N dichloridooxygen Chemical compound ClOCl RCJVRSBWZCNNQT-UHFFFAOYSA-N 0.000 description 3
- NCBFTYFOPLPRBX-UHFFFAOYSA-N dimethyl azodicarboxylate Substances COC(=O)N=NC(=O)OC NCBFTYFOPLPRBX-UHFFFAOYSA-N 0.000 description 3
- 229960003638 dopamine Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 125000005949 ethanesulfonyloxy group Chemical group 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 150000004678 hydrides Chemical class 0.000 description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 3
- 125000005929 isobutyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])OC(*)=O 0.000 description 3
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 3
- 125000005948 methanesulfonyloxy group Chemical group 0.000 description 3
- NCBFTYFOPLPRBX-AATRIKPKSA-N methyl (ne)-n-methoxycarbonyliminocarbamate Chemical compound COC(=O)\N=N\C(=O)OC NCBFTYFOPLPRBX-AATRIKPKSA-N 0.000 description 3
- 235000019426 modified starch Nutrition 0.000 description 3
- 125000006505 p-cyanobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C#N)C([H])([H])* 0.000 description 3
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 3
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 3
- 125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 description 3
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 3
- 235000015497 potassium bicarbonate Nutrition 0.000 description 3
- 239000011736 potassium bicarbonate Substances 0.000 description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 3
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 3
- 230000000069 prophylactic effect Effects 0.000 description 3
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 3
- 125000002098 pyridazinyl group Chemical group 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- YEIGUXGHHKAURB-UHFFFAOYSA-N viridine Natural products O=C1C2=C3CCC(=O)C3=CC=C2C2(C)C(O)C(OC)C(=O)C3=COC1=C23 YEIGUXGHHKAURB-UHFFFAOYSA-N 0.000 description 3
- FTTATHOUSOIFOQ-UHFFFAOYSA-N 1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazine Chemical compound C1NCCN2CCCC21 FTTATHOUSOIFOQ-UHFFFAOYSA-N 0.000 description 2
- 125000005918 1,2-dimethylbutyl group Chemical group 0.000 description 2
- 125000004721 1-methylpentylthio group Chemical group CC(CCCC)S* 0.000 description 2
- WNJSKZBEWNVKGU-UHFFFAOYSA-N 2,2-dimethoxyethylbenzene Chemical compound COC(OC)CC1=CC=CC=C1 WNJSKZBEWNVKGU-UHFFFAOYSA-N 0.000 description 2
- BOTWVFJNFXJPOU-UHFFFAOYSA-N 2-([1,2]oxazolo[5,4-b]pyridin-3-yloxy)ethanamine;dihydrochloride Chemical compound Cl.Cl.C1=CC=C2C(OCCN)=NOC2=N1 BOTWVFJNFXJPOU-UHFFFAOYSA-N 0.000 description 2
- YHSIYORWZLFYNN-UHFFFAOYSA-N 2-([1,2]oxazolo[5,4-b]pyridin-3-yloxy)ethanamine;hydrochloride Chemical compound Cl.C1=CC=C2C(OCCN)=NOC2=N1 YHSIYORWZLFYNN-UHFFFAOYSA-N 0.000 description 2
- 125000005999 2-bromoethyl group Chemical group 0.000 description 2
- ASZLJRKXFCJMBM-UHFFFAOYSA-N 2-fluoro-n-hydroxy-3-(trifluoromethyl)benzamide Chemical compound ONC(=O)C1=CC=CC(C(F)(F)F)=C1F ASZLJRKXFCJMBM-UHFFFAOYSA-N 0.000 description 2
- XWSXJUCVIRUVFF-UHFFFAOYSA-N 2-fluoro-n-hydroxy-6-methoxybenzamide Chemical compound COC1=CC=CC(F)=C1C(=O)NO XWSXJUCVIRUVFF-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- RVGLUKRYMXEQAH-UHFFFAOYSA-N 3,3-dimethyloxetane Chemical compound CC1(C)COC1 RVGLUKRYMXEQAH-UHFFFAOYSA-N 0.000 description 2
- DETCUOYSRVPARY-UHFFFAOYSA-N 3,5,7-trichloro-1,2-benzoxazole Chemical compound C1=C(Cl)C=C2C(Cl)=NOC2=C1Cl DETCUOYSRVPARY-UHFFFAOYSA-N 0.000 description 2
- PJMDBZXSQGQSDQ-UHFFFAOYSA-N 3,5-dichloro-1,2-benzoxazole Chemical compound C1=C(Cl)C=C2C(Cl)=NOC2=C1 PJMDBZXSQGQSDQ-UHFFFAOYSA-N 0.000 description 2
- AUVGGVBYFLRRQX-UHFFFAOYSA-N 3,7-dichloro-1,2-benzoxazole Chemical compound C1=CC=C2C(Cl)=NOC2=C1Cl AUVGGVBYFLRRQX-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- NXXMYNTVLHIRDD-UHFFFAOYSA-N 3-chloro-5-fluoro-1,2-benzoxazole Chemical compound FC1=CC=C2ON=C(Cl)C2=C1 NXXMYNTVLHIRDD-UHFFFAOYSA-N 0.000 description 2
- WWUNEEPZIRSXPD-UHFFFAOYSA-N 3-chloro-5-methoxy-1,2-benzoxazole Chemical compound COC1=CC=C2ON=C(Cl)C2=C1 WWUNEEPZIRSXPD-UHFFFAOYSA-N 0.000 description 2
- VBULZBXUOIAIFP-UHFFFAOYSA-N 3-chloro-5-methyl-1,2-benzoxazole Chemical compound CC1=CC=C2ON=C(Cl)C2=C1 VBULZBXUOIAIFP-UHFFFAOYSA-N 0.000 description 2
- 125000005917 3-methylpentyl group Chemical group 0.000 description 2
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- PEPBFCOIJRULGJ-UHFFFAOYSA-N 3h-1,2,3-benzodioxazole Chemical compound C1=CC=C2NOOC2=C1 PEPBFCOIJRULGJ-UHFFFAOYSA-N 0.000 description 2
- SDWOFHVNMKIWQU-UHFFFAOYSA-N 4-(trifluoromethyl)-[1,2]oxazolo[5,4-b]pyridin-3-one Chemical compound C1=CC(C(F)(F)F)=C2C(O)=NOC2=N1 SDWOFHVNMKIWQU-UHFFFAOYSA-N 0.000 description 2
- LAMXJMFSONZHOP-UHFFFAOYSA-N 4-fluoro-1,2-benzoxazol-3-one Chemical compound C1=CC(F)=C2C(O)=NOC2=C1 LAMXJMFSONZHOP-UHFFFAOYSA-N 0.000 description 2
- LYGCVGSYMVVZKP-UHFFFAOYSA-N 4-methoxy-1,2-benzoxazol-3-one Chemical compound COC1=CC=CC2=C1C(O)=NO2 LYGCVGSYMVVZKP-UHFFFAOYSA-N 0.000 description 2
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 2
- DKKJWWCWVOUYHR-UHFFFAOYSA-N 5,7-dichloro-1,2-benzoxazol-3-one Chemical compound C1=C(Cl)C=C2C(O)=NOC2=C1Cl DKKJWWCWVOUYHR-UHFFFAOYSA-N 0.000 description 2
- WIZWHBRFTCYPDN-UHFFFAOYSA-N 5-chloro-1,2-benzoxazol-3-one Chemical compound C1=C(Cl)C=C2C(O)=NOC2=C1 WIZWHBRFTCYPDN-UHFFFAOYSA-N 0.000 description 2
- SZEAMAWNIMHBOE-UHFFFAOYSA-N 5-fluoro-1,2-benzoxazol-3-one Chemical compound C1=C(F)C=C2C(O)=NOC2=C1 SZEAMAWNIMHBOE-UHFFFAOYSA-N 0.000 description 2
- ZWYKCZNUTOPIQU-UHFFFAOYSA-N 5-methoxy-1,2-benzoxazol-3-one Chemical compound COC1=CC=C2ON=C(O)C2=C1 ZWYKCZNUTOPIQU-UHFFFAOYSA-N 0.000 description 2
- HEFTWGKXJMBSLC-UHFFFAOYSA-N 7-(trifluoromethyl)-1,2-benzoxazol-3-one Chemical compound C1=CC=C2C(O)=NOC2=C1C(F)(F)F HEFTWGKXJMBSLC-UHFFFAOYSA-N 0.000 description 2
- QITZLARGFNUAIH-UHFFFAOYSA-N 7-methoxy-1,2-benzoxazol-3-one Chemical compound COC1=CC=CC2=C1ON=C2O QITZLARGFNUAIH-UHFFFAOYSA-N 0.000 description 2
- JUNCQBPTXAQOSA-UHFFFAOYSA-N 7-methyl-1,2-benzoxazol-3-one Chemical compound CC1=CC=CC2=C1ONC2=O JUNCQBPTXAQOSA-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- QUIWRJFFMZXVRI-UHFFFAOYSA-N CCCCN(CCO)C(=O)OCCCC Chemical compound CCCCN(CCO)C(=O)OCCCC QUIWRJFFMZXVRI-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 229940126062 Compound A Drugs 0.000 description 2
- NOTFZGFABLVTIG-UHFFFAOYSA-N Cyclohexylethyl acetate Chemical compound CC(=O)OCCC1CCCCC1 NOTFZGFABLVTIG-UHFFFAOYSA-N 0.000 description 2
- CUDSBWGCGSUXDB-UHFFFAOYSA-N Dibutyl disulfide Chemical compound CCCCSSCCCC CUDSBWGCGSUXDB-UHFFFAOYSA-N 0.000 description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N Phosphinothricin Natural products CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000004703 alkoxides Chemical class 0.000 description 2
- 125000005103 alkyl silyl group Chemical group 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- 125000005604 azodicarboxylate group Chemical group 0.000 description 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- HFNQLYDPNAZRCH-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O.OC(O)=O HFNQLYDPNAZRCH-UHFFFAOYSA-N 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 150000003983 crown ethers Chemical class 0.000 description 2
- 239000012024 dehydrating agents Substances 0.000 description 2
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 2
- 125000004915 dibutylamino group Chemical group C(CCC)N(CCCC)* 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- MRPGVPAVDMEQED-UHFFFAOYSA-N ethyl 2-chloro-6-methylpyridine-3-carboxylate Chemical compound CCOC(=O)C1=CC=C(C)N=C1Cl MRPGVPAVDMEQED-UHFFFAOYSA-N 0.000 description 2
- VAMUBMXKZDWUKN-UHFFFAOYSA-N ethyl n-butyl-n-(2-hydroxyethyl)carbamate Chemical compound CCCCN(CCO)C(=O)OCC VAMUBMXKZDWUKN-UHFFFAOYSA-N 0.000 description 2
- 229940005667 ethyl salicylate Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- IAJOBQBIJHVGMQ-BYPYZUCNSA-N glufosinate-P Chemical compound CP(O)(=O)CC[C@H](N)C(O)=O IAJOBQBIJHVGMQ-BYPYZUCNSA-N 0.000 description 2
- QHFNOSFIKJEMNP-UHFFFAOYSA-N gold trihydride Chemical class [AuH3] QHFNOSFIKJEMNP-UHFFFAOYSA-N 0.000 description 2
- VHGDODPKQBTSJN-UHFFFAOYSA-H gold(3+);tricarbonate Chemical class [Au+3].[Au+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O VHGDODPKQBTSJN-UHFFFAOYSA-H 0.000 description 2
- WDZVNNYQBQRJRX-UHFFFAOYSA-K gold(iii) hydroxide Chemical class O[Au](O)O WDZVNNYQBQRJRX-UHFFFAOYSA-K 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229960004502 levodopa Drugs 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 229910052987 metal hydride Inorganic materials 0.000 description 2
- 150000004681 metal hydrides Chemical class 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- WOKPPDUGASITJX-UHFFFAOYSA-N methyl 2-fluoro-6-methoxybenzoate Chemical compound COC(=O)C1=C(F)C=CC=C1OC WOKPPDUGASITJX-UHFFFAOYSA-N 0.000 description 2
- 229940102396 methyl bromide Drugs 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 2
- 125000003386 piperidinyl group Chemical group 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- LIYMTLVBAVHPBU-UHFFFAOYSA-N tert-butyl n-(4-hydroxybutyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCCCO LIYMTLVBAVHPBU-UHFFFAOYSA-N 0.000 description 2
- YULKPQRIUMFUJT-UHFFFAOYSA-N tert-butyl n-[2-[[5-(dimethylamino)-1,2-benzoxazol-3-yl]oxy]ethyl]carbamate Chemical compound CN(C)C1=CC=C2ON=C(OCCNC(=O)OC(C)(C)C)C2=C1 YULKPQRIUMFUJT-UHFFFAOYSA-N 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 2
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 2
- CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Chemical compound C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 description 2
- PFJVIOBMBDFBCJ-UHFFFAOYSA-N (1z)-1-diazobutane Chemical compound CCCC=[N+]=[N-] PFJVIOBMBDFBCJ-UHFFFAOYSA-N 0.000 description 1
- WXZAKWIDYTWOJA-UHFFFAOYSA-N (2,3,4-tributylphenyl)phosphane Chemical compound CCCCC1=CC=C(P)C(CCCC)=C1CCCC WXZAKWIDYTWOJA-UHFFFAOYSA-N 0.000 description 1
- RMZZEYDIXQHFBH-UHFFFAOYSA-N (6-ethylnaphthalen-2-yl)phosphane Chemical compound C(C)C=1C=C2C=CC(=CC2=CC1)P RMZZEYDIXQHFBH-UHFFFAOYSA-N 0.000 description 1
- 125000006729 (C2-C5) alkenyl group Chemical group 0.000 description 1
- 125000006569 (C5-C6) heterocyclic group Chemical group 0.000 description 1
- 125000004725 1,1-dimethylbutylthio group Chemical group CC(CCC)(S*)C 0.000 description 1
- KSYPAYCLSJHBKA-UHFFFAOYSA-N 1,2-benzoxazol-5-amine Chemical compound NC1=CC=C2ON=CC2=C1 KSYPAYCLSJHBKA-UHFFFAOYSA-N 0.000 description 1
- SZLDGOXCELBEBV-UHFFFAOYSA-N 1,2-benzoxazol-5-ol Chemical compound OC1=CC=C2ON=CC2=C1 SZLDGOXCELBEBV-UHFFFAOYSA-N 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- GJPDBURPGLWRPW-UHFFFAOYSA-N 1-(hexyldisulfanyl)hexane Chemical compound CCCCCCSSCCCCCC GJPDBURPGLWRPW-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- OZHIYEINSCNALY-UHFFFAOYSA-N 1-aminobutan-1-ol Chemical compound CCCC(N)O OZHIYEINSCNALY-UHFFFAOYSA-N 0.000 description 1
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
- BZWJDKJBAVXCMH-UHFFFAOYSA-N 1-diazopropane Chemical compound CCC=[N+]=[N-] BZWJDKJBAVXCMH-UHFFFAOYSA-N 0.000 description 1
- 125000004717 1-ethylpropylthio group Chemical group C(C)C(CC)S* 0.000 description 1
- HNEGJTWNOOWEMH-UHFFFAOYSA-N 1-fluoropropane Chemical group [CH2]CCF HNEGJTWNOOWEMH-UHFFFAOYSA-N 0.000 description 1
- ANOOTOPTCJRUPK-UHFFFAOYSA-N 1-iodohexane Chemical compound CCCCCCI ANOOTOPTCJRUPK-UHFFFAOYSA-N 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N 1-nonene Chemical compound CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- FZKCAHQKNJXICB-UHFFFAOYSA-N 2,1-benzoxazole Chemical compound C1=CC=CC2=CON=C21 FZKCAHQKNJXICB-UHFFFAOYSA-N 0.000 description 1
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 description 1
- 125000004728 2,2-dimethylbutylthio group Chemical group CC(CS*)(CC)C 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- SSFFGTMTYNKYBE-UHFFFAOYSA-N 2,5-dichloro-n-hydroxypyridine-3-carboxamide Chemical compound ONC(=O)C1=CC(Cl)=CN=C1Cl SSFFGTMTYNKYBE-UHFFFAOYSA-N 0.000 description 1
- WCWZJXDUFYFNAT-UHFFFAOYSA-N 2,6-difluoro-n-hydroxybenzamide Chemical compound ONC(=O)C1=C(F)C=CC=C1F WCWZJXDUFYFNAT-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 1
- GFGDEUWVEDDYRB-UHFFFAOYSA-N 2-([1,2]oxazolo[4,5-b]pyridin-3-yloxy)ethanamine Chemical compound C1=CN=C2C(OCCN)=NOC2=C1 GFGDEUWVEDDYRB-UHFFFAOYSA-N 0.000 description 1
- ZDAUPBLIBDKVSD-UHFFFAOYSA-N 2-([1,2]oxazolo[4,5-b]pyridin-3-yloxy)ethanamine;hydrochloride Chemical compound Cl.C1=CN=C2C(OCCN)=NOC2=C1 ZDAUPBLIBDKVSD-UHFFFAOYSA-N 0.000 description 1
- SHIJKCNUEKXNKZ-UHFFFAOYSA-N 2-[(5-chloro-7-methyl-1,2-benzoxazol-3-yl)sulfanyl]ethanamine Chemical compound CC1=CC(Cl)=CC2=C1ON=C2SCCN SHIJKCNUEKXNKZ-UHFFFAOYSA-N 0.000 description 1
- CSHHUVYYZCCBQN-UHFFFAOYSA-N 2-[(5-chloro-7-methyl-1,2-benzoxazol-3-yl)sulfanyl]ethanamine;hydrochloride Chemical compound Cl.CC1=CC(Cl)=CC2=C1ON=C2SCCN CSHHUVYYZCCBQN-UHFFFAOYSA-N 0.000 description 1
- QUSWXIDRBLOPAS-UHFFFAOYSA-N 2-[(7-methyl-1,2-benzoxazol-3-yl)oxy]ethanamine Chemical compound CC1=CC=CC2=C1ON=C2OCCN QUSWXIDRBLOPAS-UHFFFAOYSA-N 0.000 description 1
- SXAMGRAIZSSWIH-UHFFFAOYSA-N 2-[3-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,2,4-oxadiazol-5-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NOC(=N1)CC(=O)N1CC2=C(CC1)NN=N2 SXAMGRAIZSSWIH-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- APLNAFMUEHKRLM-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)N=CN2 APLNAFMUEHKRLM-UHFFFAOYSA-N 0.000 description 1
- GXZDYRYYNXYPMQ-UHFFFAOYSA-N 2-chloro-6-methylpyridine Chemical compound CC1=CC=CC(Cl)=N1 GXZDYRYYNXYPMQ-UHFFFAOYSA-N 0.000 description 1
- ACQXHCHKMFYDPM-UHFFFAOYSA-N 2-chloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC=C(C(O)=O)C(Cl)=N1 ACQXHCHKMFYDPM-UHFFFAOYSA-N 0.000 description 1
- BCEKGWWLVKXZKK-UHFFFAOYSA-N 2-fluoro-6-hydroxybenzoic acid Chemical compound OC(=O)C1=C(O)C=CC=C1F BCEKGWWLVKXZKK-UHFFFAOYSA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- DLGBEGBHXSAQOC-UHFFFAOYSA-N 2-hydroxy-5-methylbenzoic acid Chemical compound CC1=CC=C(O)C(C(O)=O)=C1 DLGBEGBHXSAQOC-UHFFFAOYSA-N 0.000 description 1
- 125000004714 2-methylbutylthio group Chemical group CC(CS*)CC 0.000 description 1
- 125000004722 2-methylpentylthio group Chemical group CC(CS*)CCC 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- 125000004730 3,3-dimethylbutylthio group Chemical group CC(CCS*)(C)C 0.000 description 1
- KFPNSQYMBRRLGW-UHFFFAOYSA-N 3,4-dichloro-1,2-benzoxazole Chemical compound C1=CC(Cl)=C2C(Cl)=NOC2=C1 KFPNSQYMBRRLGW-UHFFFAOYSA-N 0.000 description 1
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 description 1
- OOMPYIMJDFAOLS-UHFFFAOYSA-N 3-(trifluoromethyl)-1,2-benzoxazole Chemical compound C1=CC=C2C(C(F)(F)F)=NOC2=C1 OOMPYIMJDFAOLS-UHFFFAOYSA-N 0.000 description 1
- ALKYHXVLJMQRLQ-UHFFFAOYSA-N 3-Hydroxy-2-naphthoate Chemical compound C1=CC=C2C=C(O)C(C(=O)O)=CC2=C1 ALKYHXVLJMQRLQ-UHFFFAOYSA-N 0.000 description 1
- NCIYIIPYKCJIPS-UHFFFAOYSA-N 3-bromo-1,2-benzoxazole Chemical compound C1=CC=C2C(Br)=NOC2=C1 NCIYIIPYKCJIPS-UHFFFAOYSA-N 0.000 description 1
- INWUFXPCLZRSBH-UHFFFAOYSA-N 3-chloro-1,2-benzoxazole Chemical compound C1=CC=C2C(Cl)=NOC2=C1 INWUFXPCLZRSBH-UHFFFAOYSA-N 0.000 description 1
- JIOINBPQWQGPNL-UHFFFAOYSA-N 3-chloro-7-methoxy-1,2-benzoxazole Chemical compound COC1=CC=CC2=C1ON=C2Cl JIOINBPQWQGPNL-UHFFFAOYSA-N 0.000 description 1
- QZDGOLAEGFIKEU-UHFFFAOYSA-N 4-(1,2-benzoxazol-3-yloxy)butan-1-amine;hydrochloride Chemical compound Cl.C1=CC=C2C(OCCCCN)=NOC2=C1 QZDGOLAEGFIKEU-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 125000006281 4-bromobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Br)C([H])([H])* 0.000 description 1
- QGUKWHFYFFQJJW-UHFFFAOYSA-N 4-chloro-1,2-benzoxazol-3-one Chemical compound ClC1=CC=CC2=C1C(=O)NO2 QGUKWHFYFFQJJW-UHFFFAOYSA-N 0.000 description 1
- RKEPYRSRDOBAJC-UHFFFAOYSA-N 4-chloro-3-methyl-1,2-benzoxazole Chemical compound C1=CC(Cl)=C2C(C)=NOC2=C1 RKEPYRSRDOBAJC-UHFFFAOYSA-N 0.000 description 1
- 125000006283 4-chlorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1Cl)C([H])([H])* 0.000 description 1
- WIJSJASAYRSKBG-UHFFFAOYSA-N 4-fluoro-1,2-benzoxazole Chemical compound FC1=CC=CC2=C1C=NO2 WIJSJASAYRSKBG-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical class OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- JZQZYXDKEKPSPS-UHFFFAOYSA-N 4-methyl-1,2-benzoxazole Chemical compound CC1=CC=CC2=C1C=NO2 JZQZYXDKEKPSPS-UHFFFAOYSA-N 0.000 description 1
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
- LPAMQJCJSQGMHG-UHFFFAOYSA-N 5-chloro-1,2-benzoxazole Chemical compound ClC1=CC=C2ON=CC2=C1 LPAMQJCJSQGMHG-UHFFFAOYSA-N 0.000 description 1
- HSGGGOYVOYGCBE-UHFFFAOYSA-N 5-fluoro-1,2-benzoxazole Chemical compound FC1=CC=C2ON=CC2=C1 HSGGGOYVOYGCBE-UHFFFAOYSA-N 0.000 description 1
- UVIKIZJWOLGNSL-UHFFFAOYSA-N 5-fluoro-1,2-benzoxazole-3-carboxylic acid Chemical compound C1=C(F)C=C2C(C(=O)O)=NOC2=C1 UVIKIZJWOLGNSL-UHFFFAOYSA-N 0.000 description 1
- SEIYCEZOFVBLGP-UHFFFAOYSA-N 5-hydroxy-1,2-benzoxazol-3-one Chemical compound C1=C(O)C=C2C(O)=NOC2=C1 SEIYCEZOFVBLGP-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- LLQHSBBZNDXTIV-UHFFFAOYSA-N 6-[5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC1CC(=NO1)C1=CC2=C(NC(O2)=O)C=C1 LLQHSBBZNDXTIV-UHFFFAOYSA-N 0.000 description 1
- TZUHTZMWRNXWLN-UHFFFAOYSA-N 6-methyl-1,2-benzoxazol-3-one Chemical compound CC1=CC=C2C(O)=NOC2=C1 TZUHTZMWRNXWLN-UHFFFAOYSA-N 0.000 description 1
- VZVAQLOROCVVSN-UHFFFAOYSA-N 6-methyl-1,2-benzoxazole Chemical compound CC1=CC=C2C=NOC2=C1 VZVAQLOROCVVSN-UHFFFAOYSA-N 0.000 description 1
- RWYSKNAYUGRVTM-UHFFFAOYSA-N 6-methyl-[1,2]oxazolo[5,4-b]pyridin-3-one Chemical compound CC1=CC=C2C(O)=NOC2=N1 RWYSKNAYUGRVTM-UHFFFAOYSA-N 0.000 description 1
- KYSIZDUWPBHMQN-UHFFFAOYSA-N 7-(trifluoromethyl)-1,2-benzoxazole Chemical compound FC(F)(F)C1=CC=CC2=C1ON=C2 KYSIZDUWPBHMQN-UHFFFAOYSA-N 0.000 description 1
- PSJBNRGIWUPYOT-UHFFFAOYSA-N 7-chloro-1,2-benzoxazol-3-one Chemical compound C1=CC=C2C(O)=NOC2=C1Cl PSJBNRGIWUPYOT-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- GDIWDMZAESNBAM-UHFFFAOYSA-N C1=CC(=C2C(=C1)ON=C2SCCN)CF Chemical compound C1=CC(=C2C(=C1)ON=C2SCCN)CF GDIWDMZAESNBAM-UHFFFAOYSA-N 0.000 description 1
- 101100352919 Caenorhabditis elegans ppm-2 gene Proteins 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VOPWNXZWBYDODV-UHFFFAOYSA-N Chlorodifluoromethane Chemical compound FC(F)Cl VOPWNXZWBYDODV-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- CETBSQOFQKLHHZ-UHFFFAOYSA-N Diethyl disulfide Chemical compound CCSSCC CETBSQOFQKLHHZ-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- XONFRAXSQBJIMQ-UHFFFAOYSA-N FC(C1=CC=NC=C1C(=O)O)(F)F.FC(C1=CC=[N+](C=C1C(=O)O)[O-])(F)F Chemical compound FC(C1=CC=NC=C1C(=O)O)(F)F.FC(C1=CC=[N+](C=C1C(=O)O)[O-])(F)F XONFRAXSQBJIMQ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- VIZQREHVDDPWOK-UHFFFAOYSA-N IP(I)(I)=O Chemical compound IP(I)(I)=O VIZQREHVDDPWOK-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N Methyl salicylate Natural products COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 238000006751 Mitsunobu reaction Methods 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- NEAPKZHDYMQZCB-UHFFFAOYSA-N N-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]ethyl]-2-oxo-3H-1,3-benzoxazole-6-carboxamide Chemical compound C1CN(CCN1CCNC(=O)C2=CC3=C(C=C2)NC(=O)O3)C4=CN=C(N=C4)NC5CC6=CC=CC=C6C5 NEAPKZHDYMQZCB-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FHKPLLOSJHHKNU-INIZCTEOSA-N [(3S)-3-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxypyrrolidin-1-yl]-(oxan-4-yl)methanone Chemical compound C(C)N1N=CC(=C1C)C=1N(C2=NC=NC(=C2N=1)O[C@@H]1CN(CC1)C(=O)C1CCOCC1)C FHKPLLOSJHHKNU-INIZCTEOSA-N 0.000 description 1
- VHMSVJIBCHFSKU-UHFFFAOYSA-N [1,2]oxazolo[5,4-b]pyridin-3-one Chemical compound C1=CC=C2C(=O)NOC2=N1 VHMSVJIBCHFSKU-UHFFFAOYSA-N 0.000 description 1
- DITTYRBIXKVOTK-UHFFFAOYSA-N [1,2]oxazolo[5,4-b]pyridine Chemical compound C1=CC=C2C=NOC2=N1 DITTYRBIXKVOTK-UHFFFAOYSA-N 0.000 description 1
- GHKJXEICAPOWQS-UHFFFAOYSA-K [Au+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O Chemical compound [Au+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O GHKJXEICAPOWQS-UHFFFAOYSA-K 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- HNFXXKDUEBXQST-UHFFFAOYSA-N [O-2].[Al+3].[Rh+3] Chemical compound [O-2].[Al+3].[Rh+3] HNFXXKDUEBXQST-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 description 1
- 125000005115 alkyl carbamoyl group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- NVQOFWZLYDVFMU-UHFFFAOYSA-N azane;oxolane Chemical class N.C1CCOC1 NVQOFWZLYDVFMU-UHFFFAOYSA-N 0.000 description 1
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 1
- 210000004227 basal ganglia Anatomy 0.000 description 1
- 229940090012 bentyl Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- XGIUDIMNNMKGDE-UHFFFAOYSA-N bis(trimethylsilyl)azanide Chemical compound C[Si](C)(C)[N-][Si](C)(C)C XGIUDIMNNMKGDE-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- IMOOHQRESULGCM-UHFFFAOYSA-N butyl 3-amino-2-hydroxypropanoate Chemical compound CCCCOC(=O)C(O)CN IMOOHQRESULGCM-UHFFFAOYSA-N 0.000 description 1
- 125000006309 butyl amino group Chemical group 0.000 description 1
- KMGBZBJJOKUPIA-UHFFFAOYSA-N butyl iodide Chemical compound CCCCI KMGBZBJJOKUPIA-UHFFFAOYSA-N 0.000 description 1
- FUWNUXBTJXNBIK-UHFFFAOYSA-N butyl n-(2-hydroxyethyl)carbamate Chemical compound CCCCOC(=O)NCCO FUWNUXBTJXNBIK-UHFFFAOYSA-N 0.000 description 1
- VQQKHKBHESABFS-UHFFFAOYSA-N butyl n-(2-sulfanylethyl)carbamate Chemical compound CCCCOC(=O)NCCS VQQKHKBHESABFS-UHFFFAOYSA-N 0.000 description 1
- PAYXZLUSJAPVRT-UHFFFAOYSA-N butyl n-butoxycarbonyliminocarbamate Chemical compound CCCCOC(=O)N=NC(=O)OCCCC PAYXZLUSJAPVRT-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-M carbonochloridate Chemical compound [O-]C(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-M 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000001159 caudate nucleus Anatomy 0.000 description 1
- NEHMKBQYUWJMIP-NJFSPNSNSA-N chloro(114C)methane Chemical compound [14CH3]Cl NEHMKBQYUWJMIP-NJFSPNSNSA-N 0.000 description 1
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- PGZIKUPSQINGKT-UHFFFAOYSA-N dialuminum;dioxido(oxo)silane Chemical compound [Al+3].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O PGZIKUPSQINGKT-UHFFFAOYSA-N 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- KPUNOVLMCQQCSK-UHFFFAOYSA-N diazomethane;ethoxyethane Chemical compound C=[N+]=[N-].CCOCC KPUNOVLMCQQCSK-UHFFFAOYSA-N 0.000 description 1
- 125000004989 dicarbonyl group Chemical group 0.000 description 1
- RHMZKSWPMYAOAZ-UHFFFAOYSA-N diethyl peroxide Chemical compound CCOOCC RHMZKSWPMYAOAZ-UHFFFAOYSA-N 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- GWZCCUDJHOGOSO-UHFFFAOYSA-N diphenic acid Chemical compound OC(=O)C1=CC=CC=C1C1=CC=CC=C1C(O)=O GWZCCUDJHOGOSO-UHFFFAOYSA-N 0.000 description 1
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- SDIXRDNYIMOKSG-UHFFFAOYSA-L disodium methyl arsenate Chemical compound [Na+].[Na+].C[As]([O-])([O-])=O SDIXRDNYIMOKSG-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 230000003291 dopaminomimetic effect Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000006232 ethoxy propyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- IRTACBSCHHOIPA-UHFFFAOYSA-N ethyl 1,2-benzoxazole-3-carboxylate Chemical compound C1=CC=C2C(C(=O)OCC)=NOC2=C1 IRTACBSCHHOIPA-UHFFFAOYSA-N 0.000 description 1
- PDKGDFVCWQSRDX-UHFFFAOYSA-N ethyl 5-ethyl-2-hydroxybenzoate Chemical compound CCOC(=O)C1=CC(CC)=CC=C1O PDKGDFVCWQSRDX-UHFFFAOYSA-N 0.000 description 1
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- JFUIHGAGFMFNRD-UHFFFAOYSA-N fica Chemical compound FC1=CC=C2NC(C(=O)NCCS)=CC2=C1 JFUIHGAGFMFNRD-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- MPOKJOWFCMDRKP-UHFFFAOYSA-N gold;hydrate Chemical compound O.[Au] MPOKJOWFCMDRKP-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001245 hexylamino group Chemical group [H]N([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000005935 hexyloxycarbonyl group Chemical group 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 125000006316 iso-butyl amino group Chemical group [H]N(*)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 1
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000005921 isopentoxy group Chemical group 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940037627 magnesium lauryl sulfate Drugs 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- HBNDBUATLJAUQM-UHFFFAOYSA-L magnesium;dodecyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCOS([O-])(=O)=O HBNDBUATLJAUQM-UHFFFAOYSA-L 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- UJTKCKAJUPJNFM-UHFFFAOYSA-N methyl 1,2-benzoxazole-3-carboxylate Chemical compound C1=CC=C2C(C(=O)OC)=NOC2=C1 UJTKCKAJUPJNFM-UHFFFAOYSA-N 0.000 description 1
- CNPFXYWTMBTSSI-UHFFFAOYSA-N methyl 2,5-dichloropyridine-3-carboxylate Chemical compound COC(=O)C1=CC(Cl)=CN=C1Cl CNPFXYWTMBTSSI-UHFFFAOYSA-N 0.000 description 1
- QNPFLTKQLFSKBY-UHFFFAOYSA-N methyl 2,6-difluorobenzoate Chemical compound COC(=O)C1=C(F)C=CC=C1F QNPFLTKQLFSKBY-UHFFFAOYSA-N 0.000 description 1
- FDASGHWJBUNFFL-UHFFFAOYSA-N methyl 2-chloro-4-(trifluoromethyl)pyridine-3-carboxylate Chemical compound COC(=O)C1=C(Cl)N=CC=C1C(F)(F)F FDASGHWJBUNFFL-UHFFFAOYSA-N 0.000 description 1
- XOUMAABXMXACFQ-UHFFFAOYSA-N methyl 2-fluoro-3-(trifluoromethyl)benzoate Chemical compound COC(=O)C1=CC=CC(C(F)(F)F)=C1F XOUMAABXMXACFQ-UHFFFAOYSA-N 0.000 description 1
- KLHWBYHFWALOIJ-UHFFFAOYSA-N methyl 2-methylpyridine-3-carboxylate Chemical compound COC(=O)C1=CC=CN=C1C KLHWBYHFWALOIJ-UHFFFAOYSA-N 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- REOJLIXKJWXUGB-UHFFFAOYSA-N mofebutazone Chemical group O=C1C(CCCC)C(=O)NN1C1=CC=CC=C1 REOJLIXKJWXUGB-UHFFFAOYSA-N 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- DAZXVJBJRMWXJP-UHFFFAOYSA-N n,n-dimethylethylamine Chemical compound CCN(C)C DAZXVJBJRMWXJP-UHFFFAOYSA-N 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- ZUSSTQCWRDLYJA-UHFFFAOYSA-N n-hydroxy-5-norbornene-2,3-dicarboximide Chemical compound C1=CC2CC1C1C2C(=O)N(O)C1=O ZUSSTQCWRDLYJA-UHFFFAOYSA-N 0.000 description 1
- 125000005484 neopentoxy group Chemical group 0.000 description 1
- 210000001577 neostriatum Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- KPADFPAILITQBG-UHFFFAOYSA-N non-4-ene Chemical compound CCCCC=CCCC KPADFPAILITQBG-UHFFFAOYSA-N 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 description 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000004894 pentylamino group Chemical group C(CCCC)N* 0.000 description 1
- 125000001148 pentyloxycarbonyl group Chemical group 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-M phosphinate Chemical compound [O-][PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-M 0.000 description 1
- UXCDUFKZSUBXGM-UHFFFAOYSA-N phosphoric tribromide Chemical compound BrP(Br)(Br)=O UXCDUFKZSUBXGM-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- CUQOHAYJWVTKDE-UHFFFAOYSA-N potassium;butan-1-olate Chemical compound [K+].CCCC[O-] CUQOHAYJWVTKDE-UHFFFAOYSA-N 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 208000037821 progressive disease Diseases 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000005767 propoxymethyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])[#8]C([H])([H])* 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- 125000006308 propyl amino group Chemical group 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- ATBIAJXSKNPHEI-UHFFFAOYSA-N pyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1 ATBIAJXSKNPHEI-UHFFFAOYSA-N 0.000 description 1
- 150000004040 pyrrolidinones Chemical class 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- MEZLKOACVSPNER-GFCCVEGCSA-N selegiline Chemical compound C#CCN(C)[C@H](C)CC1=CC=CC=C1 MEZLKOACVSPNER-GFCCVEGCSA-N 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 125000005624 silicic acid group Chemical class 0.000 description 1
- NGHMEZWZOZEZOH-UHFFFAOYSA-N silicic acid;hydrate Chemical compound O.O[Si](O)(O)O NGHMEZWZOZEZOH-UHFFFAOYSA-N 0.000 description 1
- 238000009097 single-agent therapy Methods 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- LVPZIYNEFHMUEV-UHFFFAOYSA-N tert-butyl n-[2-(1,2-benzoxazol-3-yloxy)ethyl]carbamate Chemical compound C1=CC=C2C(OCCNC(=O)OC(C)(C)C)=NOC2=C1 LVPZIYNEFHMUEV-UHFFFAOYSA-N 0.000 description 1
- HSEFBFXSNKIWPP-UHFFFAOYSA-N tert-butyl n-[2-([1,2]oxazolo[4,5-b]pyridin-3-yloxy)ethyl]carbamate Chemical compound C1=CN=C2C(OCCNC(=O)OC(C)(C)C)=NOC2=C1 HSEFBFXSNKIWPP-UHFFFAOYSA-N 0.000 description 1
- GKSNFDDKMWJFRE-UHFFFAOYSA-N tert-butyl n-[2-([1,2]oxazolo[5,4-b]pyridin-3-yloxy)ethyl]carbamate Chemical compound C1=CC=C2C(OCCNC(=O)OC(C)(C)C)=NOC2=N1 GKSNFDDKMWJFRE-UHFFFAOYSA-N 0.000 description 1
- QTQNNRRTMDTZLW-UHFFFAOYSA-N tert-butyl n-[2-[(4,5-dimethyl-1,2-benzoxazol-3-yl)oxy]ethyl]carbamate Chemical compound CC1=CC=C2ON=C(OCCNC(=O)OC(C)(C)C)C2=C1C QTQNNRRTMDTZLW-UHFFFAOYSA-N 0.000 description 1
- XKBGVAXXEAZITF-UHFFFAOYSA-N tert-butyl n-[2-[(4,7-dimethyl-1,2-benzoxazol-3-yl)oxy]ethyl]carbamate Chemical compound CC1=CC=C(C)C2=C1ON=C2OCCNC(=O)OC(C)(C)C XKBGVAXXEAZITF-UHFFFAOYSA-N 0.000 description 1
- SNKRKEISTHXJKU-UHFFFAOYSA-N tert-butyl n-[2-[(5-chloro-1,2-benzoxazol-3-yl)sulfanyl]ethyl]carbamate Chemical compound C1=C(Cl)C=C2C(SCCNC(=O)OC(C)(C)C)=NOC2=C1 SNKRKEISTHXJKU-UHFFFAOYSA-N 0.000 description 1
- BAAASDKDGIQMJW-UHFFFAOYSA-N tert-butyl n-[2-[(5-fluoro-1,2-benzoxazol-3-yl)oxy]ethyl]carbamate Chemical compound C1=C(F)C=C2C(OCCNC(=O)OC(C)(C)C)=NOC2=C1 BAAASDKDGIQMJW-UHFFFAOYSA-N 0.000 description 1
- AHDHZHZUXJGRBF-UHFFFAOYSA-N tert-butyl n-[2-[(5-fluoro-1,2-benzoxazol-3-yl)sulfanyl]ethyl]carbamate Chemical compound C1=C(F)C=C2C(SCCNC(=O)OC(C)(C)C)=NOC2=C1 AHDHZHZUXJGRBF-UHFFFAOYSA-N 0.000 description 1
- IPCZGADXSYOPCT-UHFFFAOYSA-N tert-butyl n-[2-[(7-cyano-1,2-benzoxazol-3-yl)oxy]ethyl]carbamate Chemical compound C1=CC=C2C(OCCNC(=O)OC(C)(C)C)=NOC2=C1C#N IPCZGADXSYOPCT-UHFFFAOYSA-N 0.000 description 1
- VNMNCSJXNYZOJM-UHFFFAOYSA-N tert-butyl n-[3-(1,2-benzoxazol-3-yloxy)propyl]carbamate Chemical compound C1=CC=C2C(OCCCNC(=O)OC(C)(C)C)=NOC2=C1 VNMNCSJXNYZOJM-UHFFFAOYSA-N 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 125000004149 thio group Chemical group *S* 0.000 description 1
- 125000000101 thioether group Chemical group 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- RXJKFRMDXUJTEX-UHFFFAOYSA-N triethylphosphine Chemical compound CCP(CC)CC RXJKFRMDXUJTEX-UHFFFAOYSA-N 0.000 description 1
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- 125000005951 trifluoromethanesulfonyloxy group Chemical group 0.000 description 1
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 1
- DMEUUKUNSVFYAA-UHFFFAOYSA-N trinaphthalen-1-ylphosphane Chemical compound C1=CC=C2C(P(C=3C4=CC=CC=C4C=CC=3)C=3C4=CC=CC=C4C=CC=3)=CC=CC2=C1 DMEUUKUNSVFYAA-UHFFFAOYSA-N 0.000 description 1
- IDXDWPWXHTXJMZ-UHFFFAOYSA-N tris(2,4,6-trimethylphenyl)phosphane Chemical compound CC1=CC(C)=CC(C)=C1P(C=1C(=CC(C)=CC=1C)C)C1=C(C)C=C(C)C=C1C IDXDWPWXHTXJMZ-UHFFFAOYSA-N 0.000 description 1
- COIOYMYWGDAQPM-UHFFFAOYSA-N tris(2-methylphenyl)phosphane Chemical compound CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C COIOYMYWGDAQPM-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- YEIGUXGHHKAURB-VAMGGRTRSA-N viridin Chemical compound O=C1C2=C3CCC(=O)C3=CC=C2[C@@]2(C)[C@H](O)[C@H](OC)C(=O)C3=COC1=C23 YEIGUXGHHKAURB-VAMGGRTRSA-N 0.000 description 1
- 108010086097 viridin Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Definitions
- the present invention has excellent B-type monoamine oxidase inhibitory activity and A-type monoamine oxidase inhibitory activity (in particular, B-type monoamine oxidase inhibitory activity is excellent), and is useful for Parkinson's disease, depression, Alzheimer's disease
- the present invention relates to isoxazole derivatives having a therapeutic or prophylactic action for neurological diseases such as Parkinson's disease and the like and monoamine oxidase inhibitors containing the isoxazole derivative as an active ingredient.
- Parkinson's disease is a chronic progressive disease that results in immobility, muscle stiffness, and tremor as a result of degeneration of dopaminergic nerves in the nigrostriatal tract.
- the cause of Parkinson's disease is known to be due to a decrease in the content of the neurotransmitter dopamine in the brain, especially in the caudate nucleus and killing, due to degenerative, vascular, and inflammatory changes in the basal ganglia. ing.
- levodopa is most effective and widely applied to supplement dopamine in the brain, which is rarely used, especially in the striatum.
- the problem is that levodopa monotherapy has large side effects.
- Japanese Patent Publication No. 47-6302 discloses that benzoisoxazole derivatives, for example, compounds A and B, are combined with local anesthesia, antihistamines, anti-inflammatory agents, tonics and generally have an effect on the nervous system. It is described that it can be used as an antispasmodic having a circulating effect.
- the inventor of the present invention has conducted long-term studies on the synthesis and pharmacology of isoxazole derivatives with the aim of developing an excellent therapeutic agent for Parkinson's disease. It has oxidase inhibitory activity and A-type monoamine oxidase inhibitory activity (particularly strong B-type monoamine oxidase inhibitory activity), and has neurological diseases such as Parkinson's disease, depression, and Alzheimer's disease (especially Parkinson's disease)
- the present invention has been found to have a therapeutic or prophylactic action on the present invention.
- the present invention provides an isoxazole derivative having excellent B-type monoamine oxidase inhibitory activity and A-type monoamine oxidase inhibitory activity, a process for producing the same, and a monoamine oxidase inhibitor containing the isoxazole derivative as an active ingredient.
- the isoxazole derivative of the present invention has the general formula (I),
- R ' is a hydrogen atom; a halogen atom; a C, -C alkyl group;
- D-C alkyl group substituted with C, -C alkoxy; -C alkoxy group; halogeno C, -C alkoxy group; hydroxyl group; C, -C alkylthio group; amino group; mono-C, -C alkylamino group; di (, - C alkylamino group;!
- C - C Arukanoiru groups C, - C Arca noisy Rua amino groups; C, - C Al Kanoiruokishi groups; C, one C 6 alkoxycarbonyl group; a carboxy group; (C, one C alkylthio) thiocarbonyl group; carbamoyl group; mono C, -C alkyl rubamoyl group; di-C, -C alkyl rubamoyl group; nitro group; or a cyano group;
- R 2 represents an amino group
- n an integer of 1 to 3
- n an integer of 1 to 6
- Ring A is a phenyl ring condensed with isoxazole, a naphthyl ring condensed with isoxazole, or a heteroatom composed of oxygen, nitrogen and sulfur atoms condensed with isoxazole, 1 to 2 A 5- or 6-membered aromatic heterocyclic ring containing a hetero atom;
- X represents an oxygen atom or a sulfur atom.
- R 1 represents the same or different groups.
- the active ingredient of the monoamine oxidase inhibitor of the present invention is represented by the following general formula (II): Isoxazole derivative,
- R 2 a is amino group mono- C, - C alkylamino group; di C, - C alkylamino group; Or a 5- to 6-membered heterocyclic group that contains one nitrogen atom and may further contain one nitrogen or oxygen atom (however, the group is bonded on the nitrogen atom).
- halogen atom in the definition of R 1 in the above general formulas (I) and (II) may be, for example, a fluorine atom, a chlorine atom, a bromine atom or an iodine atom, preferably a fluorine atom, a chlorine atom or A bromine atom, more preferably a fluorine atom or a chlorine atom.
- di-C 6 alkyl group is, for example, a methyl group, an ethyl group, a bromo group, or an isopropyl group.
- the “halogen or C, -C alkyl group substituted with C, -C 4 alkoxy” in the definition of R ′ is the halogen or the C, -C Lucoxy represents a group bonded to the -C alkyl group.
- the group bonded to the alkyl group include a fluoromethyl group, a difluoromethyl group, a trifluoromethyl group, a 2-fluoroethyl group, and a 2-chloroethyl group. , twenty two ,
- It may be a 3-bromopropyl group, a 4-fluorobutyl group or a 4-chlorobutyl group.
- Examples of the group in which the alkoxy is bonded to the alkyl group include a methoxymethyl group, an ethoxymethyl group, a propoxymethyl group, a butoxymethyl group, and a methoxyxyl.
- 2,2,2-trifluoroethyl methoxymethyl or methoxethyl, more preferably fluoromethyl, difluoromethyl, trifluoromethyl, 2-fluoroethyl, 2,2,2-trifluoroethyl Group, metoki
- a methyl group or main Tokishechiru group more preferably a preparative Rifuruoromechiru group, 2, 2, 2-preparative Rifuruoroechiru group or main Tokishimechiru group, is particularly suitable for the Bok Rifuruoromechiru group.
- I ′ C, —C 6 alkoxy group in the definition of R 1 represents a group in which the above “C, —C 6 alkyl group” is bonded to an oxygen atom, and includes, for example, a methoxy group, an ethoxy group, and a propoxy group.
- halogeno C, -C alkoxy group in the definition of R ′ is Wherein the serial halogen atom C, - C 6 shows the bonded groups to alkoxy groups, for example, full Ruorome butoxy group, chloromethane Bok alkoxy group, Puromome butoxy group, ® one domain Bok alkoxy group, Jifuruorome Bok alkoxy group, Jikurorome Bok alkoxy Group, dibromomethoxy group, trifluoromethoxy group, trichloromethoxy group, 11-fluoroethoxy group, 2-fluoroethoxy group, 2-chloroethoxy group, 2.2,2-trifluoroethoxy group , 2,2,2-trichloromouth ethoxy group, 3-fluorobromoboxyl group, 3-bromopropoxy group, 4-fluorobutoxy group, 5-fluoropentoxy group or 6-hexoxyhexyloxy group.
- a fluoromethoxy group preferably a chloromethoxy group, a difluoromethoxy group, a dichloromethoxy group, a trifluoromethoxy group, or a trichloromethoxy group.
- a trifluoromethoxy group or a 2,2,2-trifluoromethoxy group particularly preferably a difluoromethoxy group.
- “(:, -C alkylthio group)” in the definition of R 1 represents a group in which the above “C 1 -C ⁇ alkyl group” is bonded to a sulfur atom, and is, for example, a methylthio group, an ethylthio group, a propylthio group, an isobrovir group.
- Pentylthio group isopentylthio group, 2-methylbutylthio group, neopentylthio group, 1-ethylpropylthio group, hexylthio group, 4 —Methylpentylthio, 3-methylpentylthio, 2-methylbentylthio, 1,1-methylpentylthio, 3,3-dimethylbutylthio, 2,2-dimethylbutylthio, 1,1-dimethylbutyl Thio, 1,2-dimethylbutylthio, 1,3-dimethylbutylthio, 2,3-dimethylbutylthio or 2-phenyl Be a Rupuchiruchio group, preferably is C, one C 4 ⁇ alkylthio group, more preferably a methylthio group or an Echiruchio group, particularly preferably a methylthio group.
- the “mono C, -C alkylamino group” in the definition of R ′ represents a group in which the above “C, one C 6 alkyl group” is bonded to an amino group. It may be a mino group, an ethylamino group, a propylamino group, an isopropylamino group, a butylamino group, an isobutylamino group, an s-butylamino group, a t-butylamino group, a pentylamino group or a hexylamino group, and is preferably mono-C, -C. It is an alkylamino group, more preferably a methylamino group or an ethylamino group, and particularly preferably a methylamino group.
- di-C alkylamino group in the definition of R ′ is, for example, a dimethylamino group, an ethylmethylamino group, a methylpropylamino group, an isopropylmethylamino group, a butylmethylamino group, Butylmethylamino group, s-butylmethylamino group, t-butylmethylamino group, getylamino group, ethylpropylamino group, ethylisobutylamino group, dibutyl amino group, dibutylamino group, dipentylamino Or a dihexylamino group, preferably a di-C ⁇ alkylamino group, more preferably a dimethylamino group or a dimethylamino group, particularly preferably a dimethylamino group.
- d-C 6 alkanoyl group in the definition of R 1 includes, for example, a carbon atom such as a formyl group, an acetyl group, a propionyl group, a butyryl group, an isobutyryl group, a pentanoyl group, a bivaloyl group, a valeryl group, or an isovaleryl group. It may be a straight-chain or branched-chain alkanol group having a number of 1 to 6, preferably a d-Calkyl group, more preferably a formyl group or an acetyl group.
- C, -C alkanoylamino in the definition of R 1 is, for example, formylamino, acetylamino, propionylamino, butyrylamino, isobutyrylamino, pentanoylamino, It may be a linear or branched alkanoylamino group having 1 to 6 carbon atoms, such as a bivaloylamino group, a valerylamino group or an isovalerylamino group, and is preferably a d-Calkanoylamino group. And more preferably a formylamino group or an acetylamino group.
- C, -C alkanoyloxy group in the definition of R ′ is, for example, formyloxy, acetyloxy, brobionyloxy, butyryloxy, isoptyryloxy, pentanoyloxy Straight-chain or straight-chain having 1 to 6 carbon atoms such as a group, bivaloyloxy, valeryloxy or isovaleryloxy. It may be a branched alk Noi Ruo alkoxy group, preferably a C, - a C 4 Arukanoiruo alkoxy group, more preferably a Horumiruokishi group or Asechiruokishi group.
- C, -C alkoxycarbonyl group in the definition of R ′ is, for example, a methoxycarbonyl group, an ethoxycarbonyl group, a propoxycarbonyl group, an isopropoxycarbonyl group, a butoxycarbonyl group, an isobutoxycarbonyl group, It may be an s-butoxycarbonyl group, a butoxycarbonyl group, a pentoxycarbonyl group or a hexyloxycarbonyl group, preferably a -C alkoxycarbonyl group, more preferably a methoxycarbonyl group or an ethoxycarbonyl group. And particularly preferably a methoxycarbonyl group.
- (C, 1C 6 alkylthio) thiocarbonyl in the definition of R 1 is, for example, (methylthio) thiocarbonyl, (ethylthio) thiocarbonyl, (propylthio) thiocarbonyl, or (isopropylthio) thiocarbo.
- thiocarbonyl group having a linear or branched alkylthio group having 1 to 6 carbon atoms such as (C, -C alkylthio) thiocarbonyl group, and more preferably ( Methylthio) thiocarbonyl group or (ethylthio) thiocarbo A group, particularly preferably a (methylthio) Chio carbonyl group.
- the “mono C, -C alkyl rubamoyl group” in the definition of R 1 is, for example, a methylcarbamoyl group, an ethylcarbamoyl group, a bromocarbyl group, an isopropylcarbyl group, a butylcarbamoyl group, an isobutylcarbamoyl group.
- the “di d-C 6 alkyl group rubamoyl group” in the definition of R 1 is, for example, a dimethylcarbamoyl group, an ethylmethylcarbamoyl group, a getylcal Bamoyl group, dibumoyl rubamoyl group, diisopropyl rubamoyl group, dibutylcarbamoyl group, diisobutylcarbamoyl group, di-S-butylcarbamoyl group, dibutylbutylcarbamoyl group, dipentylcarbamoyl group or dihexylcarbamoyl group It can be, preferably, a di (:, -C 4 alkyl group), more preferably, a dimethylcarbamoyl group or a getylcarbamoyl group, particularly preferably, a dimethylcarbamoyl group.
- ring A a 5- to 6-membered aromatic ring containing 1 to 2 hetero atoms selected from the group consisting of hetero atoms consisting of oxygen, nitrogen and sulfur atoms, which is condensed with isoxazole.
- the heterocyclic group J is, for example, a furyl, cheryl, pyrrolyl, imidazolyl, virazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, pyridyl, virazinyl, pyrimidinyl or pyridazinyl ring And is preferably a furyl ring, a cyenyl ring or a pyridyl ring, and more preferably a pyridyl ring.
- the isoxazole compound condensed with a furyl ring, a chenyl ring or a pyridyl ring is, for example, a compound having the following structural formulas (III) to (XII), and preferably has the structural formulas (III), (IV) and (IX). ), (X), (XI) or (XII), more preferably a compound having the structural formula (IX), (X), (XI) or (XII), and still more preferably Is a compound having the structural formula (IX) or (XII), and is particularly preferably a compound having the structural formula (XII).
- Di C, one C 4 alkylamino group in the definition of R 2 a in the above are the same meanings as defined for R 1 described above, preferably a Jimechiruamino group.
- R 1 is a basic group such as an amino group or an alkylamino group
- the compound is treated with an acid according to a conventional method.
- Each can be made into corresponding pharmacologically acceptable salts.
- the compound (I) or (II) is treated with a corresponding acid in a solvent (for example, ethers, especially dioxane) at a room temperature for 5 to 30 minutes, and the precipitated crystals are collected or reduced pressure. It can be obtained by removing the solvent.
- a solvent for example, ethers, especially dioxane
- Such salts include mineral salts such as hydrochloride, hydrobromide, hydroiodide, nitrate, perchlorate, sulfate or phosphate: methanesulfonate, trifluoromethanesulfonate Sulfonates such as ethanesulfonate, benzenesulfonate or p-toluenesulfonate; carbohydrates such as fumarate, succinate, citrate, tartrate, oxalate or maleate; Or amino acid salts such as glutamate or aspartate.
- mineral salts such as hydrochloride, hydrobromide, hydroiodide, nitrate, perchlorate, sulfate or phosphate: methanesulfonate, trifluoromethanesulfonate Sulfonates such as ethanesulfonate, benzenesulfonate or p-toluenesulfonate
- carbohydrates such as
- R 1 in the compounds (I) and (II) of the present invention is an acidic group such as a hydroxyl group or a carboxyl group
- the compound is treated with a base according to a conventional method to obtain the corresponding pharmacologically.
- a base for example, ethers, particularly ether or tetrahydrofuran
- the compound (I) or (II) is treated with a corresponding base in a solvent (for example, ethers, particularly ether or tetrahydrofuran) at room temperature for 5 to 30 minutes, and the precipitated crystals are collected or It can be obtained by distilling off the solvent under reduced pressure.
- a solvent for example, ethers, particularly ether or tetrahydrofuran
- salts examples include alkaline metal salts such as sodium or potassium salts, alkaline earth metal salts such as calcium salts or magnesium salts, or guanidine, triethylamine or dicyclohexylamine.
- Organic base salts can be mentioned.
- the compound (I) or (II) or a salt thereof of the present invention absorbs water, adsorbs water, or hydrates when left in the air or recrystallized.
- the compound salt containing such water may be included in the present invention.
- the compound (I) or (II) of the present invention or a salt thereof may have an asymmetric carbon in the molecule, and each may have a stereoisomer having an R configuration or an S configuration. However, each of them, or a mixture thereof in any proportion thereof, is included in the present invention.
- preferred compounds include
- C alkylthio group amino group, mono C, -C alkylamino group, di-, 1-C alkylamino group, formyl group, acetyl group, formylamino group, acetylamino group, -C alkanoyloxy group, d- C alkoxycarbonyl group, carboxy group, (methylthio) thiocarbonyl group, (ethylthio) thiocarbonyl group, carbamoyl group, methylcarbamoyl group, ethylcarbamoyl group, dimethylcarbamoyl group, getylcarbamoyl group, nitro group or cyano
- the compound that is the base
- R 1 is a hydrogen atom, a halogen atom, a -C * alkyl group, a fluoromethyl group, a difluoromethyl group, a trifluoromethyl group, a 2-fluoroethyl group, a 2,2,2-tritrifluoroethyl group, a methoxymethyl group, Toxityl group, C-C alkoxy group, difluoromethyoxy group, hydroxyl group, C, -C alkylthio group, amino group, methylamino group, ethylamino group, dimethylamino group, methylamino group, formyl group, acetyl group, formylamino group , Acetylamino,
- R 1 force hydrogen atom, fluorine atom, chlorine atom, bromine atom, methyl group, ethyl group, trifluoromethyl group, methoxy group, ethoxy group, difluoromethyoxy group, hydroxyl group, methylthio group, ethylthio group, amino Compounds which are methoxy, methylamino, ethylamino, dimethylamino, formyloxy, acetyloxy, methoxycarbonyl, ethoxycarbonyl, carboxy, carbamoyl, nitro or cyano, (4) R 'force; a compound that is a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, a methyl group, a methoxy group, a methylthio group, a difluoromethoxy group, a methoxycarbonyl group, a nitro group, or a cyano group;
- Ring A is a phenyl ring, a naphthyl ring, a furyl ring, a chelyl group, a pyrrolyl ring, an imidazolyl ring, a pyrazolyl ring, a thiazolyl ring, an isothiazolyl ring, an oxazolyl ring, an isoxazolyl ring, a pyridyl ring, a virazinyl ring, a bilimidinyl ring Or a compound which is a pyridazinyl ring,
- ring A is a fuunyl ring, a naphthyl ring or a pyridyl ring
- Ring A is a phenyl ring or a pyridyl ring
- Ring A is a phenyl ring
- R i is a hydrogen atom, a halogen atom, a C, -C alkyl group, a fluoromethyl group, a difluoromethyl group, a trifluoromethyl group, a 2-fluoroethyl group, a 2-cycloethyl group, a 2,2,2 Rifuruoroechiru group, main Tokishimechiru group, main Bok Kishechiru group, C, one C 4 alkoxy group, Furuorome butoxy group, chloromethane preparative alkoxy group, Jifuruorome butoxy group, Jikurorome butoxy group, preparative Rifuruorome Bok alkoxy group, Application Benefits chloromethane butoxy group, 1 1-Fluoroethoxy group, 2—Fluoroethoxy group, 2—Chloroethoxy group, 2,2,2—Tri
- (2) 1 is a hydrogen atom, a halogen atom, a d-alkyl group, a fluoromethyl group, a difluoromethyl group, a trifluoromethyl group, a 2-fluoroethyl group, a 2,2,2—a trifluoroethyl group, a methoxymethyl group, a methyl group Kishetyl group, C
- -C alkoxy group difluoromethoxy group, hydroxyl group, Ct-C alkylthio group, amino group, methylamino group, ethylamino group, dimethylamino group, methylamino group, formyl group, acetyl group, formylamino group, acetylamino Group,
- R 'force hydrogen atom, fluorine atom, chlorine atom, bromine atom, methyl group, ethyl group, trifluoromethyl group, methoxy group, ethoxy group, difluromethyloxy group, hydroxyl group, methylthio group, ethylthio group, Amino group, methylamino group, ethylamino group, dimethylamino group, formyloxy group, acetyloxy group, methoxycarbonyl group, ethoxycarbonyl group, carboxy group, carbamoyl group, nitro group or Is a compound that is a cyano group,
- R 'force A compound that is a hydrogen atom, a fluorine atom, a chlorine atom, a bromine atom, a methyl group, a methoxy group, a methylthio group, a difluoromethoxy group, a methoxycarbonyl group, a nitro group, or a cyano group;
- R 2 a is Amino group, Mechiruamino group, Jimechiruamino group, piperidino group or morpholino group compound,
- R 2 a is Amino group, compounds piperidinyl group or morpholinyl group, (7) Compound R 2 a is an Amino group,
- Ring A is phenyl, naphthyl, furyl, phenyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, oxazolyl, isoxazolyl, pyridyl, virazinyl, pyridyl A compound which is a midinyl ring or a pyridazinyl ring,
- Ring A is a phenyl, naphthyl or pyridyl ring
- Representative compounds of the present invention include, for example, the compounds described in the following table, but the present invention is not limited to these compounds.
- (R 1 ) represents one substituent, two substituents or three substituents on ring A as a whole.
- 3E 2 z C s s z z: a.
- Preferred compounds in the isoxazole derivative having the general formula (I) of the present invention include 113, 1 -1 3, 1 1 1 5, 1 1 1 9, 1 1 2 2, 1 1 2 5, 1 1 28, 1 — 3 1, 1 1 38, 1 1 4 1, 1 1 44, 1 1 47, 1-148, 1-149, 1-150, 1-151, 1-53, 1-156, 1-159, 1-160, 1-162, 1 — 66, 1-168, 1- 6 9, 1 1 7 2, 1 1 75, 1 1 7 6, 1 1 85, 1 1 96, 1-97, 1-98,-1 0 7-1 1 9-1 2 2-1 2 5 — 1 2 6,
- More preferred compounds include 113, 1-1-3, 1-15-1, 1-22, 1-2.
- Particularly preferred compounds include
- suitable compounds include 1-3, 1-13, 1-15, 11-1 1 9, 1 1 2 2, 1-2 5.1 1 2 8, 1 1 3 1, 1 1 38, 1 4 1, 1 1 44, 1 1 47, 1 1 48, 1 — 4 9, 1 1 50, 1 5 1 1, 1 5 3, 1 1 56, 1 1 59, 1 — 60, 1 — 6 2, 1 1 6 6, 1 1 68, 1 1 69, 1 1 7 2 1 75 , 1-176, 1-185, 1-196, 1-197, 1-98, -107-119,
- More preferred compounds include 113, 113, 113, 115—1, 222, 1-28, 311, 118, 1-444, 115, 1, 1-1. 53, 1-159, 1-60, 1-162, 1-168, 1-69, 1-175, 1-176, 1-185, 1-197, 1-198, 1-10, 1 1 1 1 9.
- Particularly preferred compounds include
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
Description
Claims
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU32660/95A AU688102B2 (en) | 1994-08-30 | 1995-08-29 | Isoxazoles |
CZ1997598A CZ290961B6 (cs) | 1994-08-30 | 1995-08-29 | Deriváty isoxazolu, způsob a meziprodukt pro jejich přípravu |
KR1019970701279A KR970705549A (ko) | 1994-08-30 | 1995-08-29 | 이속사졸류(isoxazoles) |
EP95929249A EP0779281B1 (en) | 1994-08-30 | 1995-08-29 | Isoxazoles |
NZ291508A NZ291508A (en) | 1994-08-30 | 1995-08-29 | Isoxazoles; preparation and medicaments |
DE69532039T DE69532039T2 (de) | 1994-08-30 | 1995-08-29 | Isoxazole |
HK98113089.8A HK1018878B (en) | 1994-08-30 | 1995-08-29 | Isoxazoles |
HU9701740A HU221138B1 (en) | 1994-08-30 | 1995-08-29 | Condensed isoxazolyloxy- and -thioalkylamine derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
RU97103132/04A RU2140414C1 (ru) | 1994-08-30 | 1995-08-29 | Производные изоксазола, их применение в производстве ингибирующего моноаминооксидазу агента, фармацевтическая композиция и способ ингибирования моноаминооксидазы типа в |
AT95929249T ATE253057T1 (de) | 1994-08-30 | 1995-08-29 | Isoxazole |
DK95929249T DK0779281T3 (da) | 1994-08-30 | 1995-08-29 | Isoxazoler |
MX9701630A MX9701630A (es) | 1994-08-30 | 1995-08-29 | Isoxazoles. |
US08/806,854 US5965591A (en) | 1994-08-30 | 1997-02-26 | Isoxazole derivatives |
NO970892A NO308741B1 (no) | 1994-08-30 | 1997-02-27 | Isoksazolderivater, mellomprodukter, farmasøytiske preparater og anvendelse av derivatene |
FI970864A FI970864A7 (fi) | 1994-08-30 | 1997-02-28 | Isoksatsolijohdannaiset |
US09/243,885 US6096771A (en) | 1994-08-30 | 1999-02-03 | Isoxazole derivatives |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6/205363 | 1994-08-30 | ||
JP20536394 | 1994-08-30 | ||
JP7/150571 | 1995-06-16 | ||
JP15057195 | 1995-06-16 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/806,854 Continuation US5965591A (en) | 1994-08-30 | 1997-02-26 | Isoxazole derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996006837A1 true WO1996006837A1 (en) | 1996-03-07 |
Family
ID=26480122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1995/001714 WO1996006837A1 (en) | 1994-08-30 | 1995-08-29 | Isoxazoles |
Country Status (19)
Country | Link |
---|---|
US (2) | US5965591A (ja) |
EP (1) | EP0779281B1 (ja) |
KR (1) | KR970705549A (ja) |
CN (1) | CN1098843C (ja) |
AT (1) | ATE253057T1 (ja) |
AU (1) | AU688102B2 (ja) |
CA (1) | CA2198457A1 (ja) |
CZ (1) | CZ290961B6 (ja) |
DE (1) | DE69532039T2 (ja) |
DK (1) | DK0779281T3 (ja) |
ES (1) | ES2208690T3 (ja) |
FI (1) | FI970864A7 (ja) |
HU (1) | HU221138B1 (ja) |
MX (1) | MX9701630A (ja) |
NO (1) | NO308741B1 (ja) |
NZ (1) | NZ291508A (ja) |
PT (1) | PT779281E (ja) |
RU (1) | RU2140414C1 (ja) |
WO (1) | WO1996006837A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965591A (en) * | 1994-08-30 | 1999-10-12 | Sankyo Company, Limited | Isoxazole derivatives |
EP0885891A4 (en) * | 1996-02-27 | 2001-02-21 | Sankyo Co | ISOXAZOLE DERIVATIVES |
US8012955B2 (en) | 2006-12-28 | 2011-09-06 | Rigel Pharmaceuticals, Inc. | N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6339099B1 (en) * | 1997-06-20 | 2002-01-15 | Dupont Pharmaceuticals Company | Guanidine mimics as factor Xa inhibitors |
WO2000027199A1 (en) * | 1998-11-12 | 2000-05-18 | Eli Lilly And Company | Aminobenzisoxazole compounds and libraries thereof |
US6497928B1 (en) | 1999-05-14 | 2002-12-24 | Canon Kabushiki Kaisha | Liquid crystal device, mesomorphic functional material and liquid crystal apparatus |
DE10000577A1 (de) | 2000-01-10 | 2001-07-26 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten |
US6638981B2 (en) | 2001-08-17 | 2003-10-28 | Epicept Corporation | Topical compositions and methods for treating pain |
US6660736B2 (en) * | 2002-03-27 | 2003-12-09 | Hoffmann-La Roche Inc. | Phthalimido derivatives and a process for their preparation |
MY134480A (en) * | 2002-09-20 | 2007-12-31 | Hoffmann La Roche | 4-pyrrolidino-phenyl-benzyl ether derivatives |
NZ548212A (en) * | 2003-12-29 | 2010-07-30 | Sepracor Inc | Pyrrole and pyrazole DAAO inhibitors |
CN102010382A (zh) * | 2003-12-29 | 2011-04-13 | 塞普拉科公司 | 苯并[d]异噁唑-3-醇DAAO抑制剂 |
EP1746991A2 (en) * | 2004-03-16 | 2007-01-31 | Janssen Pharmaceutica N.V. | Daao inhibiting benzisoxazoles for treating mental disorders |
WO2006013049A2 (en) * | 2004-08-02 | 2006-02-09 | F.Hoffmann-La Roche Ag | Benzyloxy derivatives as maob inhibitors |
DE102005018389A1 (de) * | 2005-04-20 | 2006-10-26 | Sanofi-Aventis Deutschland Gmbh | Azolderivate als Inhibitoren von Lipasen und Phospholipasen |
WO2007006003A2 (en) | 2005-07-06 | 2007-01-11 | Sepracor Inc. | Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders |
KR20080038369A (ko) * | 2005-07-28 | 2008-05-06 | 버텍스 파마슈티칼스 인코포레이티드 | 카스파제 억제제 프로드럭 |
CA2636275C (en) * | 2006-01-06 | 2013-02-12 | Sepracor Inc. | Tetralone-based monoamine reuptake inhibitors |
US20070203111A1 (en) | 2006-01-06 | 2007-08-30 | Sepracor Inc. | Cycloalkylamines as monoamine reuptake inhibitors |
RU2434002C2 (ru) * | 2006-02-21 | 2011-11-20 | Тояма Кемикал Ко., Лтд. | Способ получения сложного эфира 3-[5-[4-(циклопентилокси)-2-гидроксибензоил]-2-[(3-оксо-2-замещенный-2, 3-дигидро-1, 2-бензизоксазол-6-ил)метокси]фенил]пропионовой кислоты и промежуточного продукта для данного способа |
US8097760B2 (en) | 2006-03-31 | 2012-01-17 | Sunovion Pharmacuticals Inc. | Preparation of chiral amides and amines |
US7579370B2 (en) * | 2006-06-30 | 2009-08-25 | Sepracor Inc. | Fused heterocycles |
US7884124B2 (en) * | 2006-06-30 | 2011-02-08 | Sepracor Inc. | Fluoro-substituted inhibitors of D-amino acid oxidase |
US20080082066A1 (en) * | 2006-10-02 | 2008-04-03 | Weyerhaeuser Co. | Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks |
ZA200904686B (en) * | 2007-01-18 | 2010-09-29 | Sepracor Inc | Inhibitiors of D-amino acid oxidase |
US7902252B2 (en) * | 2007-01-18 | 2011-03-08 | Sepracor, Inc. | Inhibitors of D-amino acid oxidase |
NZ580429A (en) | 2007-05-31 | 2012-04-27 | Sepracor Inc | Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors |
WO2009104080A2 (en) | 2008-02-20 | 2009-08-27 | Targia Pharmaceuticals | Cns pharmaceutical compositions and methods of use |
US20100120740A1 (en) * | 2008-08-07 | 2010-05-13 | Sepracor Inc. | Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
US20110034434A1 (en) * | 2009-08-07 | 2011-02-10 | Sepracor Inc. | Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
CA2789434A1 (en) | 2010-02-11 | 2011-08-18 | Vanderbilt University | Benzisoxazoles and azabenzisoxazoles as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
US9630929B2 (en) | 2011-10-31 | 2017-04-25 | Xenon Pharmaceuticals Inc. | Benzenesulfonamide compounds and their use as therapeutic agents |
WO2013064984A1 (en) | 2011-10-31 | 2013-05-10 | Xenon Pharmaceuticals Inc. | Biaryl ether sulfonamides and their use as therapeutic agents |
US8952169B2 (en) | 2012-05-22 | 2015-02-10 | Xenon Pharmaceuticals Inc. | N-substituted benzamides and methods of use thereof |
US10071957B2 (en) | 2012-07-06 | 2018-09-11 | Genentech, Inc. | N-substituted benzamides and methods of use thereof |
KR20150131233A (ko) | 2013-03-14 | 2015-11-24 | 제넨테크, 인크. | 치환된 트리아졸로피리딘 및 이의 사용 방법 |
MX2015010775A (es) | 2013-03-15 | 2016-04-25 | Genentech Inc | Benzoxazoles sustituidos y metodos para usarlos. |
CN105492430B (zh) * | 2013-03-15 | 2017-10-10 | 基因泰克公司 | 取代的苯并噁唑及其使用方法 |
EA201691085A1 (ru) | 2013-11-27 | 2017-02-28 | Дженентек, Инк. | Замещенные бензамиды и способы их применения |
JP2017525677A (ja) | 2014-07-07 | 2017-09-07 | ジェネンテック, インコーポレイテッド | 治療用化合物及びその使用方法 |
AU2016268120A1 (en) | 2015-05-22 | 2017-11-30 | Genentech, Inc. | Substituted benzamides and methods of use thereof |
JP2018526371A (ja) | 2015-08-27 | 2018-09-13 | ジェネンテック, インコーポレイテッド | 治療化合物及びその使用方法 |
WO2017091592A1 (en) | 2015-11-25 | 2017-06-01 | Genentech, Inc. | Substituted benzamides useful as sodium channel blockers |
JP2019513714A (ja) | 2016-03-30 | 2019-05-30 | ジェネンテック, インコーポレイテッド | 置換ベンズアミド及びその使用方法 |
CN105801510A (zh) * | 2016-04-08 | 2016-07-27 | 李勇 | 一种治疗抑郁症的药物组合物 |
RU2019114964A (ru) | 2016-10-17 | 2020-11-17 | Дженентек, Инк. | Терапевтические средства и способы их применения |
US10793550B2 (en) | 2017-03-24 | 2020-10-06 | Genentech, Inc. | 4-piperidin-n-(pyrimidin-4-yl)chroman-7-sulfonamide derivatives as sodium channel inhibitors |
EP3759098A1 (en) | 2018-02-26 | 2021-01-06 | Genentech, Inc. | Pyridine-sulfonamide compounds and their use against pain and related conditions |
EP3774801A1 (en) | 2018-03-30 | 2021-02-17 | F. Hoffmann-La Roche AG | Fused ring hydro-pyrido compounds as sodium channel inhibitors |
TW202003490A (zh) | 2018-05-22 | 2020-01-16 | 瑞士商赫孚孟拉羅股份公司 | 治療性化合物及其使用方法 |
CN114349690B (zh) * | 2022-02-15 | 2023-04-25 | 甘肃皓天医药科技有限责任公司 | 一种多拉韦林中间体合成方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5229734B1 (ja) * | 1970-02-05 | 1977-08-03 | ||
WO1994007490A1 (en) * | 1992-09-30 | 1994-04-14 | The Mount Sinai School Of Medicine Of The City University Of New York | Method and composition for the treatment of parkinson's disease |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1265824A (ja) * | 1968-03-28 | 1972-03-08 | ||
US3812187A (en) * | 1970-02-05 | 1974-05-21 | Merck & Co Inc | Hydrazides |
JPS476302Y1 (ja) * | 1970-06-08 | 1972-03-04 | ||
US5321037A (en) * | 1986-12-26 | 1994-06-14 | Sankyo Company, Limited | Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants |
IE62276B1 (en) * | 1988-03-30 | 1995-01-25 | Sankyo Co | "New isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants" |
US5116839A (en) * | 1989-06-26 | 1992-05-26 | Sankyo Company, Limited | Use of isoxazolin-3-one derivatives as antidepressants |
US5750542A (en) * | 1993-09-28 | 1998-05-12 | Pfizer | Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors |
JPH0588630A (ja) * | 1991-09-30 | 1993-04-09 | Toshiba Lighting & Technol Corp | 表示装置 |
WO1994010158A1 (en) * | 1992-10-28 | 1994-05-11 | Toyama Chemical Co., Ltd. | Novel 1,2-benzisoxazole derivative or salt thereof, and brain protective agent comprising the same |
US5494908A (en) * | 1992-11-23 | 1996-02-27 | Hoechst-Roussel Pharmaceutical Incorporated | Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
KR970705549A (ko) * | 1994-08-30 | 1997-10-09 | 가와무라 요시부미 | 이속사졸류(isoxazoles) |
CA2190708A1 (en) * | 1995-12-08 | 1997-06-09 | Johannes Aebi | Aminoalkyl substituted benzo-heterocyclic compounds |
JP5229734B2 (ja) * | 2008-11-26 | 2013-07-03 | 住化エンビロサイエンス株式会社 | 木材保存組成物 |
-
1995
- 1995-08-29 KR KR1019970701279A patent/KR970705549A/ko not_active Abandoned
- 1995-08-29 PT PT95929249T patent/PT779281E/pt unknown
- 1995-08-29 DK DK95929249T patent/DK0779281T3/da active
- 1995-08-29 MX MX9701630A patent/MX9701630A/es unknown
- 1995-08-29 NZ NZ291508A patent/NZ291508A/xx unknown
- 1995-08-29 WO PCT/JP1995/001714 patent/WO1996006837A1/ja active IP Right Grant
- 1995-08-29 DE DE69532039T patent/DE69532039T2/de not_active Expired - Fee Related
- 1995-08-29 CZ CZ1997598A patent/CZ290961B6/cs not_active IP Right Cessation
- 1995-08-29 CN CN95195758A patent/CN1098843C/zh not_active Expired - Fee Related
- 1995-08-29 RU RU97103132/04A patent/RU2140414C1/ru not_active IP Right Cessation
- 1995-08-29 AT AT95929249T patent/ATE253057T1/de not_active IP Right Cessation
- 1995-08-29 CA CA002198457A patent/CA2198457A1/en not_active Abandoned
- 1995-08-29 EP EP95929249A patent/EP0779281B1/en not_active Expired - Lifetime
- 1995-08-29 ES ES95929249T patent/ES2208690T3/es not_active Expired - Lifetime
- 1995-08-29 HU HU9701740A patent/HU221138B1/hu not_active IP Right Cessation
- 1995-08-29 AU AU32660/95A patent/AU688102B2/en not_active Ceased
-
1997
- 1997-02-26 US US08/806,854 patent/US5965591A/en not_active Expired - Fee Related
- 1997-02-27 NO NO970892A patent/NO308741B1/no unknown
- 1997-02-28 FI FI970864A patent/FI970864A7/fi not_active IP Right Cessation
-
1999
- 1999-02-03 US US09/243,885 patent/US6096771A/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5229734B1 (ja) * | 1970-02-05 | 1977-08-03 | ||
WO1994007490A1 (en) * | 1992-09-30 | 1994-04-14 | The Mount Sinai School Of Medicine Of The City University Of New York | Method and composition for the treatment of parkinson's disease |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965591A (en) * | 1994-08-30 | 1999-10-12 | Sankyo Company, Limited | Isoxazole derivatives |
US6096771A (en) * | 1994-08-30 | 2000-08-01 | Sankyo Company, Limited | Isoxazole derivatives |
EP0885891A4 (en) * | 1996-02-27 | 2001-02-21 | Sankyo Co | ISOXAZOLE DERIVATIVES |
US8012955B2 (en) | 2006-12-28 | 2011-09-06 | Rigel Pharmaceuticals, Inc. | N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
US8697727B2 (en) | 2006-12-28 | 2014-04-15 | Rigel Pharmaceuticals, Inc. | N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
US9181220B2 (en) | 2006-12-28 | 2015-11-10 | Rigel Pharmaceuticals, Inc. | N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
Also Published As
Publication number | Publication date |
---|---|
NZ291508A (en) | 1999-07-29 |
NO970892L (no) | 1997-04-29 |
NO308741B1 (no) | 2000-10-23 |
CN1162957A (zh) | 1997-10-22 |
EP0779281B1 (en) | 2003-10-29 |
HUT77225A (hu) | 1998-03-02 |
EP0779281A4 (en) | 2000-07-26 |
NO970892D0 (no) | 1997-02-27 |
MX9701630A (es) | 1997-06-28 |
PT779281E (pt) | 2004-02-27 |
KR970705549A (ko) | 1997-10-09 |
DE69532039T2 (de) | 2004-07-08 |
AU3266095A (en) | 1996-03-22 |
HK1018878A1 (en) | 2000-01-07 |
DK0779281T3 (da) | 2004-03-08 |
EP0779281A1 (en) | 1997-06-18 |
RU2140414C1 (ru) | 1999-10-27 |
ATE253057T1 (de) | 2003-11-15 |
AU688102B2 (en) | 1998-03-05 |
ES2208690T3 (es) | 2004-06-16 |
DE69532039D1 (de) | 2003-12-04 |
US6096771A (en) | 2000-08-01 |
CZ290961B6 (cs) | 2002-11-13 |
FI970864A7 (fi) | 1997-04-24 |
CZ59897A3 (en) | 1997-07-16 |
FI970864A0 (fi) | 1997-02-28 |
US5965591A (en) | 1999-10-12 |
HU221138B1 (en) | 2002-08-28 |
CN1098843C (zh) | 2003-01-15 |
CA2198457A1 (en) | 1996-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996006837A1 (en) | Isoxazoles | |
CA2648019C (en) | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 | |
JP5624762B2 (ja) | 新規ピロリノン誘導体およびそれを含有する医薬組成物 | |
ES2614355T3 (es) | Derivados de glicina N-sustituida con piridazin-diona como inhibidores de HIF hidoxilasas | |
ES2550479T3 (es) | Derivados de heteroarilo bicíclico condensado | |
WO2017215464A1 (zh) | 反吲哚啉环丙胺类化合物及其制备方法、药物组合物和用途 | |
WO2006019020A1 (ja) | 置換されたウレア化合物 | |
IL126558A (en) | Benzofuran carboxamides and pharmaceutical compositions containing them | |
EA022076B1 (ru) | Производные гексафторизопропил карбамата, их получение и их терапевтическое применение | |
JP7408819B2 (ja) | イソインドリン誘導体、並びにその医薬組成物及び使用 | |
US9951044B2 (en) | Quinazoline derivatives and their use as DNA methyltransferase inhibitors | |
JP2024524766A (ja) | Rnaヘリカーゼdhx33を阻害する多環式化合物及びその応用 | |
JP2011526594A (ja) | 抗腫瘍活性を有する、hsp90調節性5−フェニル−イソオキサゾール−3−カルボキシアミド | |
US7999000B2 (en) | N-(2-amino-phenyl)-acrylamides | |
US20100069328A1 (en) | Novel ortho-aminoanilides for the treatment of cancer | |
ES2204171T3 (es) | Derivados de furopiridina y su utilizacion terapeutica. | |
HU208522B (en) | Process for producing alkylene-diamines and pharmaceutical compositions containing them | |
WO2015149656A1 (zh) | 一类2,2'-串联双噻唑类化合物及其制备方法和用途 | |
Alagarsamy et al. | Synthesis of 3-(2-pyridyl)-2-substituted-quinazolin-4 (3H)-ones as new analgesic and anti-inflammatory agents | |
WO2004037828A1 (ja) | 光学活性なスルホキシドの製造法 | |
JP4549690B2 (ja) | 3−フェノキシ−4−ピリダジノール誘導体を含有する除草性組成物 | |
KR100820039B1 (ko) | 히스톤 디아세틸라제 저해활성을 갖는 알킬아미노나프탈렌일옥시메틸 프로페닐 하이드록시벤즈아마이드유도체, 이의 제조방법 및 이를 유효성분으로 하는항암제용 약학 조성물 | |
WO2003104240A1 (ja) | 環状チオエーテル類の製造法及びその合成中間体 | |
JP4567345B2 (ja) | 3−フェノキシ−4−ピリダジノール誘導体を含有する農薬 | |
WO2004006924A1 (en) | Aryl piperidine derivatives and use thereof to reduce elevated levels of ldl-cholesterol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 95195758.9 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA CN CZ FI HU KR MX NO NZ RU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1995929249 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2198457 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 291508 Country of ref document: NZ Ref document number: PV1997-598 Country of ref document: CZ Ref document number: 08806854 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019970701279 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 970864 Country of ref document: FI |
|
WWP | Wipo information: published in national office |
Ref document number: 1995929249 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV1997-598 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1019970701279 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019970701279 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: PV1997-598 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 1995929249 Country of ref document: EP |